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Whole-cell biocatalysts are preferred in many biocatalysis applications. However, 
cell envelope often represents a formidable permeability barrier. As a result, reactions 
catalyzed by whole-cells are reportedly orders of magnitude slower than those of by their 
free enzyme counterparts. The present research addresses this critical issue by using 
membrane engineering approaches. Two E. coli strains with genetically altered outer 
membrane structures were used in the study, a lipopolysaccarides (LPS) mutant SM101 
and a Braun’s lipoprotein mutant E609L. The effects of outer membrane mutation on the 
permeability of substrates differing substantially in size and hydrophobicity were 
investigated by combining the mutant cells with model enzymes. The reduction of the 
outer membrane permeability barrier by these mutations led to significant accelerations 
x 
xi 
(2– to 14–fold) in reaction rates of all whole-cell catalyzed reactions investigated. In the 
case of tetrapeptide, LPS mutation of the outer membrane can render the outer membrane 
completely permeable to substrate, a barrier-less condition that maximizes the reaction 
rate. For reaction rates of toluene dioxygenase (TDO)-catalyzed reactions, a dramatic 
increase of up to six fold was observed with the lipoprotein mutant for each of the three 
small, hydrophobic substrates tested. Mutations in either the LPS or in the Braun’s 
lipoprotein are effective for accelerating reactions with UDP-glucose, resulting in a 
striking acceleration (up to 14–fold) of reaction rate. The magnitude of reaction rate 
acceleration was found to be dependent upon the substrate concentrations, the enzyme 
expression level, and on the nature of the mutations and substrates. In addition, the 
mutations have been demonstrated to be far more superior to common permeabilization 
procedures like freeze-thaw (FT) or treatment with the chelating agent EDTA (ethylene 
diamine tetraacetic acid). Importantly, lipoprotein mutant E609L exhibited a normal 
growth rate and expressed the recombinant multi-component enzyme as well as the 
isogenic parent. The exact nature of lpp lipoprotein mutation in E609L was further 
studied and deletion of lpp was successfully introduced into E. coli strain with different 
genetic background for whole-cell biocatalysis applications. An example was provided by 
introducing an lpp deletion into an E. coli O44K74 strain to achieve a higher yield for L-
carnitine production. This research and the results outlined in this dissertation 
demonstrate a valid strategy for addressing permeability issues in whole-cell biocatalysis. 
The work also highlights a need for accessing substrate permeabilities in biocatalysis 
research and development.  
 CHAPTER 1 Introduction 
 
1.1 Background 
Over the last two decades, the rising economic and medical importance of natural 
products and an ever-increasing pressure to mitigate the adverse impact of synthetic 
production practices have stimulated interest in the use of biocatalysis as a production 
tool. According to estimatesT 1 , by 2010, the share of biocatalysis processes in the 
production of various chemical products will increase from 5% to about 20%, about $280 
billion increase in the market value of products produced using biocatalysis. Another 
estimation2 showed that 30–60% of all fine chemicals production is anticipated to involve 
a biocatalytic process step in 5 years. 
Compared to isolated enzymes, whole-cell biocatalysis has a number of attributes 
that are particularly attractive for large-scale applications. First, the use of whole cells 
instead of free enzymes is more economical as the use of whole cell eliminates the need 
for tedious, expensive protein isolation and purification. Also, whole cell biocatalysis 
allows cascades of enzymatic reactions that involve multiple enzymes, cofactors, and 
substrates while the same reaction might be too complicated to perform in vitro. 
Moreover enzymes are generally more stable when protected by cell envelopes3, 4.  
In general, the reactions catalyzed by whole cells are 10– to 100–fold slower than 
rates observed for free enzyme reactions. The difference is usually attributed to the mass 
transport barrier imposed by cellular envelopes. For example, isonovalal synthesis from 
α-pinene oxide catalyzed by Pseudomonas rhodesiae whole cells was increased by 60–
 1 
2 
fold after permeabilizing the cells5. In another recent study, mass transfer across a 
recombinant E. coli cell membrane caused a reduction in the Baeyer-Villiger oxidations 
of biocyclo[3.2.0] by almost ten fold6. In a more dramatic case, intact Pseudomonas 
pseudoalcaligenes cells showed no activity to maleate (substrate) in the process of D-
malate production; the cell membrane completely blocked the entry of the substrate7. 
Other studies documenting the mass transfer limitations imposed by cell membranes 
during whole-cell biocatalysis have also been reported8, , 10, 11, 129 . 
This often-encountered mass transport problem has thus far limited the 
commercial application of whole-cell biocatalysis. Current permeabilizing methods 
involve chemical treatments with detergents, solvents, chelators, or physical treatments 
such as extreme temperature fluctuations. All these methods are highly empirical, and are 
generally undesirable for large scale applications. Permeabilization treatments inevitably 
create additional steps in manufacturing processes, complicate downstream processing, 
and incur unintended damage to cells. Cell damage is particularly problematic as it 
disrupts the normal membrane functions and intracellular metabolism needed for efficient 
cofactor regeneration.  
 
 
 
3 
1.2 Objectives  
 The goal of this research is to accelerate the whole-cell biocatalysis reactions via 
genetic alteration of a cell membrane to mitigate or eliminate mass transport resistance to 
substrates. Eventually, we hope to be able to rationally engineer the cell membrane to 
enhance the permeability of a chosen substrate. The specific objectives of the study are: 
1) To illustrate the use of two specific E. coli outer mutations (Lipid A and Braun’s 
lipoprotein) to increase the permeability of substrates with different size and 
hydrophobicity.  
2) To establish the correlations between the effects of the mutations on mass transport 
rates to the molecular properties of the substrates, and a generally applicable 
membrane modification method to accelerate the whole-cell biocatalysis reaction rate. 
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1.3 Rationale and Approaches 
The outer membrane of Gram-negative bacteria cell envelope is a distinct 
bilayered structure. It is chemically different from usual biological membranes and has 
the ability to resist damaging chemicals. The outer leaflet of the outer membrane, 
lipopolysaccharide (LPS), is a highly ordered quasi-crystalline structure with very low 
fluidity and very low permeability to especially hydrophobic molecules. The LPS 
consists of lipophilic Lipid A, an oligosaccharide core, and a long polysaccharide chain 
comprising up to 40 sugars (called an O-specific chain). The hydrophilic polysaccharide 
component is responsible for the exclusion of hydrophobic molecules and the 
hydrophobic Lipid A of LPS limits the entry of hydrophilic compounds. The outer 
membrane of Gram-negative bacteria excludes even small hydrophobic compounds, and 
requires dedicated protein-based mechanisms for the entry of some larger hydrophilic 
molecules smaller than 600–700 Daltons. Passive diffusion through porin channels of the 
outer membrane is the mass transport mechanism for small hydrophilic compounds. Even 
with porins, diffusion may be slower than desired10. 
The rate of entry of molecules is often the rate-limiting step of a biocatalysis 
reaction. Since many biocatalysis substrates are synthetic hydrophobic and/or relatively 
big molecules and lack a natural uptake system, obtaining rapid substrate permeation 
through outer membranes is a common and formidable obstacle in whole-cell 
biocatalysis. In this study, we accelerate whole-cell biocatalysis by genetic modification 
of the outer membrane of a host cell to increase the permeability of the cell membrane to 
specific substrates. Two outer membrane mutants with genetic modifications at different 
5 
sites of the outer membrane were studied. The first mutant has a mutation inactivated the 
first enzyme in the LPS synthesis pathway, UDP-N-acetylglucosamine acyltransferase, 
resulting in an approximately 30% reduction in LPS synthesis. Another modification 
targeted a Braun’s lipoprotein, a structural protein that connects the peptidoglycan with 
the inner leaflet of the outer membrane. This protein is the most abundant protein in a 
numerical sense in E. coli. About one-third of the lipoprotein molecules are covalently 
linked to murein and help hold the two structures together.  Mutants defective in the 
structural gene for this protein are fully viable, indicating the gene is nonessential. 
However, the disruption of the lipoprotein likely affects the global membrane integrity 
and thus may cause some changes in substrate permeability. Our approach is first to 
interrogate the existing outer membrane mutants with different substrates and then 
rationally engineer the cell membrane for the whole-cell biocatalysis application. The 
approach is illustrated in Figure 1–1. 
 
Figure 1–1. Illustration of the mechanism and permeability assay of E. coli whole-cell 
catalysis investigated in this study.  
6 
1.4 Organization of the Dissertation 
This dissertation comprises 6 chapters as follows. 
Chapter 1. Introduction 
Chapter 2. Markedly Enhanced Whole-Cell Catalyzed Reaction Rates by Genetic 
Modification of Outer Membranes 
Chapter 3. Acceleration of a Permeability Limited Toluene Dioxygenase–Catalyzed 
Reaction via Lipoprotein Mutation 
Chapter 4. The Effect of Outer Membrane Mutations on UDP–Glucose Permeability and 
Whole-Cell Catalysis Rates 
Chapter 5. The Significance and Application of lpp Lipoprotein Mutation in Whole-Cell 
Biocatalysis 
Chapter 6. Summary 
The experimental chapters contain the data and analyses used to prepare the three 
publications from these studies. Thus, the dissertation is organized according to the 
chronology of the work carried out. Chapter 2–4 therefore cover different aspects of 
genetic modification of cell membrane to enable improved permeability of interrogating 
substrates. In all, we studied the effect of two membrane mutations on the permeability of 
six substrates differing substantially in hydrophobicity and size. 
In chapter 2, the effects of two outer membrane mutations on permeability of two 
substrates with different hydrophobicity are reported. By combining these two mutants 
with two model enzymes (β-lactamase and subtilisin) expressed in periplasmic space, we 
7 
were able to quantify the effects of the mutations on reaction rates with their respective 
substrates, nitrocefin (hydrophilic) and a tetrapeptide (hydrophobic).  
In the work described in Chapter 3, the effect of lipoprotein mutation on the 
permeability of three small, hydrophobic substrates was evaluated with another model 
enzyme, toluene dioxygenase. 
Chapter 4 reports the results of a study on Lipid A and lipoprotein mutations that 
were interrogated using a relatively large and hydrophilic molecule, UDP-glucose. This 
study considered two UDP-glucose utilizing reactions catalyzed by UDP-glucose 
dehydrogenase and UDP-galactose 4’-epimerase/β-1,4-galactosyltransferase fusion 
protein. The application of these mutants for whole-cell biocatalysis was illustrated by 
synthesizing a disaccharide, N-acetyllactosamine.  
Mutation of lpp lipoprotein had a significant effect on the permeability of all six 
substrates tested. We therefore studied the genetic sequence of lpp lipoprotein mutation 
and introduced this mutation into E. coli strains with different genetic backgrounds. 
Chapter 5 discusses the effectiveness of this mutation on the production of L-carnitine by 
E. coli O44K74 strain with lpp lipoprotein to achieve a higher yield of production.  
The significance and the potential impact of this research are summarized in 
Chapter 6. This final chapter also reiterates the major finding of these studies and offers 
recommendations for the future work. 
 CHAPTER 2 
Markedly Enhanced Whole-Cell Catalyzed Reaction Rates by Genetic Modification 
of Outer Membranes 
 
Whole-cell biocatalysts are preferred in many biocatalysis applications3,4. 
However, due to the permeability barriers imposed by cell envelopes, whole-cell 
catalyzed reactions are often 10–to–100 times slower than reactions catalyzed by free 
enzymes. In this study, we reduced the membrane permeability barrier of E. coli strains 
by genetically altering the membrane structure. A lipopolysaccarides E. coli mutant 
(SM101) and a Braun’s lipoprotein mutant (E609L) were used in this study. Two model 
substrates that differ substantially in size and hydrophobicity, nitrocefin and the 
tetrapeptide N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, were employed to interrogate the 
outer membrane of the cells. The reduction of the outer membrane permeability by 
genetic methods led to significant increases (up to 380%) in reaction rates of whole-cell 
catalyzed reactions. The magnitude of the increase in biocatalysis rates was dependent on 
the substrates and on the nature of the mutations introduced in the outer membrane 
structure. Notably, some outer membrane mutations can render the outer membrane 
completely permeable to one substrate, a barrier-less condition that maximizes the 
reaction rate. The impact of the mutations introduced on the permeability barrier of the 
membranes was compared to the impact of polymixin B nonapeptide, a known potent 
permeabilizer acting on lipopolysaccharides. Based on our findings, genetic 
modifications to enhance the permeability of hydrophilic molecules should target the 
Lipid A region. However, molecular engineering strategies other than reduction of Lipid 
 8 
9 
A synthesis should be considered. As we have demonstrated with tetrapeptide, membrane 
engineering can be much more effective than exogenous permeabilizers in reducing the 
permeability barrier imposed by cell walls. To our knowledge, this study is the first use of 
molecular membrane engineering techniques to address the substrate permeability 
limitations encountered in biocatalysis applications.  
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2.1 Introduction 
Whole cell biocatalysis are preferred to purified enzymes especially for large-
scale applications because it is usually more economical, easier and stable to use, 
particularly for reactions involving multiple enzymes or cofactor regenerations,. However, 
whole cell biocatalysis generally exhibits much slower reaction rates than does the use of 
free enzymes due to the mass transfer limitations imposed by low permeability cellular 
membranes. This often-encountered difficulty limits the application of whole-cell 
biocatalysis. It’s been recently reported that the membrane permeability barrier cause a 
reduction in the reaction rate for about 60–fold in a study of whole-cell catalyzed 
isonovalal synthesis from α-pinene oxide, almost ten fold for a Baeyer-Villiger 
oxidations with recombinant E. coli  cells. And more dramatically, the intact 
Pseudomonas pseudoalcaligenes cells showed no activity to maleate (substrate) in D-
malate production.  
Current permeabilizing methods involve physical and/or chemical treatment of 
host cells. These methods are generally developed by trial-and-error and inevitably add 
several steps to a bioprocess synthesis. For example, permeabilizing cells with 1 % 
toluene, a commonly used procedure, requires five steps11. In addition, permeabilizer 
residues complicate downstream purification processing, especially when a surfactant is 
used to permeabilize the cell. Furthermore, excessive membrane damage and cell lysis 
are often observed when chemical permeabilizing agents are employed. Such damage 
precludes efficient cofactor regeneration since the regeneration process requires normal 
membrane function and intracellular metabolism. 
11 
The molecular basis of permeability limitations is well-known. The outer 
membrane of Gram-negative bacteria12 (Figure 2–1A) excludes even small hydrophobic 
compounds, and allows the entry of some larger hydrophilic molecules (<700 Daltons) 
through dedicated protein-based structures, aptly called porins. Passive diffusion through 
porin channels (Figure 2–1A) of the outer membrane is the mass transport mechanism for 
small hydrophilic compounds. Even with porins, diffusion may be slower than desired. 
The lipopolysaccharide (LPS) (Figure 2–1A and Figure 2–1B) monolayer is a highly 
ordered, quasi-crystalline structure with very low fluidity, and the layer does not allow 
rapid diffusion of molecules. The LPS (Figure 2–1B) comprises lipophilic Lipid A, an 
oligosaccharide core, and a long polysaccharide chain containing up to 40 sugars 
(indicated in Figure 2-1B as the O-specific side chain). The hydrophilic polysaccharide 
component is responsible for the exclusion of hydrophobic molecules and the 
hydrophobic Lipid A of LPS limits the entry of hydrophilic compounds.  
The molecular size and/or hydrophobicity of most biocatalysis substrates of 
commercial interest limit or preclude their entry into host cells by naturally established 
transport mechanisms. The concomitant limitation of biocatalysis reaction rates is 
therefore a commonly encountered and formidable obstacle to the commercialization of 
whole-cell biocatalysis synthesis. 
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(A) 
 
(B) 
Figure 2–1. A: Gram-negative envelope. B:  Lipopolysaccharide structure. (adopted 
from Prescott et al., 2002) 
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In order to mitigate the mass transport limitations in whole-cell biocatalysis 
systems, we are genetically altering the barrier membrane to increase the transport rates 
of chosen substrates through the membrane. In this study, the effects of genetic 
modifications at two sites of the outer membrane were investigated. One modification 
affects the LPS synthesis pathway. An LPS mutant with approximately 30% reduction in 
LPS synthesis was used to probe the changes in biocatalysis reaction rates caused by the 
mutation. Another membrane modification targeted a Braun’s lipoprotein (Figure 2–1A), 
a structural protein that connects the peptidoglycan with the inner leaflet of the outer 
membrane. In order to isolate the outer membrane for permeation studies, the model 
enzymes we used (β-lactamase and subtilisin) were expressed in periplasmic space. Their 
respective substrates, nitrocefin and a tetrapeptide, differ substantially in size and 
hydrophobicity, and were used as model substrates to probe the mutation effect on 
reaction rates.  
 
 
 
 
 
 
 
 
 
14 
2.2 Experimental 
2.2.1 Chemicals 
All chemicals were reagent grade and used as received. Nitrocefin was obtained 
from Oxoid Ltd. (Basingstoke, Hampshire, United Kingdom). Tetrapeptide, N-succinyl-
Ala-Ala-Pro-Phe-p-nitroanilide (AAPF-pNA) and polymyxin B nonapeptide (PMBN) 
were obtained from Sigma (St. Louis, Mo).  
2.2.2 Sterile control 
All vessels and media used for cell cultures were autoclaved at 121oC for 15 
minutes. All tips, pipettes and tubes were purchased in disposable, sterile form. All cell 
culture operations were performed in a class II biological safety cabinet to avoid air-
borne contamination. 
2.2.3 Escherichia coli strains and plasmids 
 E. coli strains and plasmids used in this study are shown in Table 2–1. pBR322 is 
a commonly used cloning vector in E. coli with a low copy number of about 20 per cell. 
pBR322 contains bla gene, coding for β-lactamase that confers resistance to ampicillin. 
The expression of β-lactamase is constitutively driven by P1 and P3 promoters (no 
inducer required), and the expression level is comparable between strains13, 14. The signal 
sequence in bla gene allows translocation of β-lactamase to periplasmic space15.  
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 Plasmid pGES201 was graciously supplied by Dr. Dordick (RPI). This plasmid 
was constructed by inserting WT-sprE (a wild-type gene for subtilisin E) into a 
commercial pBAD/gIII plasmid (Invitrogen) for periplasmic expression of subtilisin E. 
The signal peptide from the bacteriophage fd gene III (gIII) permits secretion of subtilisin 
E into periplasmic space. araBAD promoter (pBAD) provides tight (low basal expression 
level without inducer L-arabinose), dose-dependent regulation of WT-sprE gene 
expression using arabinose as an inducer16. 
Two types of E. coli host strains were used in this study. The lipid A mutant 
SM101(lpxA2) is a thermo-sensitive, UDP-N-acetylglucosamine acyltransferase (lpxA) 
defective strain17, . Its isogenic parent strain, SM105, was used as a control. E609L is a 
periplasmic leaky E. coli host in which the gene encoding Braun’s lipoprotein was 
disrupted by a Tn10 insertion into the lpp gene18. E609 was its isogenic parent and was 
used as a control.  
Strains SM101/pBR322, SM105/pBR322, E609L/pBR322 and E609/pBR322 for 
study with nitrocefin were constructed by transforming the four host strains (Table 2–1) 
with plasmid pBR322 using a Bio-Rad Micropulser following the standard procedures19. 
Similarly, strains SM101/pGES201, SM105/pGES201, E609L/pGES201 and 
E609/pGES201 were constructed by transformation of the host strains with plasmid 
pGES201 for study with tetrapeptide. 
 Figure 2–2 is a block diagram illustrating the experimental protocol used in this 
study.  Detailed descriptions of the procedures referred to in the various blocks in Figure 
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2–2 follow below. Additionally, the terms used for various preparations (i.e., supernatant, 
cell pellet, etc.) are indicated in Figure 2–2 as a quick reference for the reader. 
 
Table 2–1. E.  coli strains and plasmids used in this study.   
 
Description Source 
Strains   
SM101 lpxA2 mutant, thermosensitive, 
grows well at 28oC 
M. Vaara 
(Martti.Vaara@Helsinki.fi) 
SM105 lpx A2+, isogenic parent of  SM101 M. Vaara 
E609L lpp::Tn10; periplasmic leaky; Tcr K. W. Miller, 25 
(labcin@uwyo.edu) 
E609 HfrC pps, isogenic parent of  E609L K. W. Miller , 25
Plasmids   
pBR322 periplasmic β-lactamase encoding 
plasmid 
R. I. Lehrer 
(rlehrer@mednet.ucla.edu) 
pGES201 subtilisin E ( serine protease) gene 
WT-sprE in pBAD/gIII 
J. Dordick 
(dordick@rpi.edu) 
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2. Seed culture preparation: inoculate liquid culture stored at -80oC in 15 %
glycerol (v/v) into 5 ml of LB medium and incubate overnight as a seed culture (as
described in 2.2.4). 
1. Recombinant strain preparation: transformation of plasmid into the host strain
by electroporation (as described in 2.2.3).  
 
 
 
 
 
 
 
 
 
3. Cell preparation: inoculate an overnight seed culture into 10 ml of LB medium
for whole cell preparation. Cells were harvested by centrifugation and washed once.
Centrifuged cells are recovered as “pellet”. (as described in 2.2.4, 2.2.5).  
 
 
 
 
 cell pellet
4. Whole-cell activity: 
cell pellets were resuspended in
buffer for whole-cell activity assay
(as described in 2.2.4, 2.2.5, 2.2.7). 
 
Sonication and centrifugation 
pellet 
supernatant
6. Periplasmic fraction activity: 
supernatant from lysozyme/osmotic 
shock treatment was analyzed for 
periplasmic fraction activity 
(as described in 2.2.6).  
 
7. Activity in supernatant 
cell pellet
5. Lysozyme/osmotic shock
treatment: periplasmic fraction
extraction (as described in 2.2.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 supernatant
 
 
 
 
 
 
 
 
 8. Cell-free extract activity: combined activity from blocks 6 and 7 
 
 
Figure 2–2. Block diagram illustrating the sequence of preparative steps and assays used 
for the measurements reported in this study. 
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2.2.4 Whole-cell β-lactamase activity assay with nitrocefin  
All pBR322 transformants were grown in LB medium. The LB medium contained 
10g/L tryptone, 5 g/L bacto-yeast extract, and 10g/L NaCl. SM101/pBR322, 
SM105/pBR322, E609L/pBR322 and E609/pBR322 were grown in 10 ml of LB medium 
containing 50 µg/ml ampicillin (to maintain selective pressure for ampicillin resistant 
gene carrying plasmid pBR322 in these strains) in a 50 ml flask and each inoculated with 
an overnight culture of (2% inocula). SM101/pBR322, which is thermo-sensitive, was 
grown at 28 oC; the others were grown at 37oC. All cultures were continuously shaken at 
250 rpm until OD600 (the optical density at 600 nm) reached around 0.5. Cells were 
harvested by centrifugation at 4000 × g for 10 minutes at 4oC and washed once with 10 
mM sodium phosphate buffer (pH 7.4) using a pipette. Cell pellets were then prepared by 
centrifugation. The pellets were isolated and then resuspended in 5 ml of sodium 
phosphate buffer (pH 7.4). Resuspension was accomplished by covering the cells with the 
buffer and then drawing the mixture into a pipette. 
The nitrocefin reaction rates were measured by the Angus method with some 
modifications 20 . The reaction was carried out in a micro-cuvette. 100 µl of cell 
suspension prepared as above was diluted with 860 µl of 10 mM sodium phosphate buffer 
(pH7.4). The reaction was started by adding 40 µl of 0.5 mg/ml nitrocefin (20 µg/ml final 
concentration). The total assay volume was 1 ml. Initial velocities of nitrocefin cleavage 
(extinction coefficient ε500 = 15,000 M–1 cm–1) were monitored by measuring the 
absorption at 500 nm at room temperature with a UV/VIS spectrophotometer (Lambda 40 
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Spectrometer, Perkin Elmer). Similar preparations without cell suspension or without 
nitrocefin addition were used as controls. One unit of β-lactamase activity was defined as 
the amount of enzyme required to hydrolyze 1 µmol of nitrocefin per minute at room 
temperature (typically 22°C ± 1°C). The typical range of cell density (absorption at 600 
nm) for a reaction mixture was between 0.09 OD600 and 0.11 OD600 (corresponding to 
about 0.2 g wet cell/liter). The activities were normalized by OD600 to correct for small 
differences in cell density between the various preparations.  
2.2.5 Whole-cell subtilisin activity assay with tetrapeptide  
The expression of functional subtilisin E in E. coli strains was performed 
according to methods described in the literature. 10 ml of LB medium with 100 µg/ml 
ampicillin in a 50 ml flask was inoculated with an overnight culture of SM101/pGES201, 
SM105/pGES201, E609L/pGES201 and E609/pGES201 (2% inocula). The thermo-
sensitive SM101/pGES201, which is thermo-sensitive, was grown at 28 oC; all others 
were grown at 37 oC. All cultures were continuously shaken at 250 rpm until OD600 
reached around 0.5. Cells were harvested by centrifugation at 4000 × g for 10 minutes at 
4oC and resuspended in a complete minimal (CM, an enriched medium containing all of 
the growth requirements of a strain) of equal volume. CM Medium contained 10.50 g/L 
K2HPO4, 11.25 g/L KH2PO4, 1.00 g/L (NH4)2SO4, 0.50 g/L sodium citrate·2H2O, 0.25 
g/L MgSO4·7H2O, and 0.015 g/L CaCl2·2H2O. Other supplements included all 20 amino 
acids at a final concentration of 40 µg/ml each, 5 mg/L vitamin B1, 0.20 % (v/v) glycerol, 
and 100 µg/ml ampicillin. Inducer arabinose was added to a final concentration of 0.10 % 
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(w/v). After induction, the incubation continued for 2–to–6 hours at 20oC with shaking to 
achieve comparable expression levels. 100 µl cells were harvested by centrifugation at 
4000 × g for 10 minutes at 4 oC. Cell pellets were resuspended in 200 µl of 10 mM 
sodium phosphate buffer (pH 7.4) and AAPF-pNA was added to a final concentration of 
300 µM. The reactions were carried out in 96-well microtiter plates for 120 minutes at 30 
oC. Initial velocities of p-NA release (extinction coefficient ε405 = 9.33 × 10-3 µM-1 cm-1) 
from AAPF-NA were measured spectrophotometrically at 405 nm in a Wallac 1420 
Victor3 Multi-label Counter (Perkin Elmer). One unit of subtilisin E activity was defined 
as the amount of enzyme required to hydrolyze 1 µmol of AAPF-pNA per minute at 30 
oC. As with β-lactamase activities, subtilisin activities were normalized by absorption 
measured at 600 nm to correct for small differences in cell density between samples.  
2.2.6 Preparation of periplasmic fractions 
A combined lysozyme and osmotic shock treatment21 was used to extract the 
periplasmic fraction. Cell pellets harvested from 4 ml of broth were resuspended in 2 ml 
of OSI (osmotic shock buffer I) containing 100 µg/ml lysozyme. The OSI contained 200 
mM Tris-HCl (pH 7.8), 2.5 mM EDTA, 2 mM CaCl2, and 20% sucrose. The suspension 
was incubated quiescently at room temperature for 15 minutes before an equal volume of 
ice-cold, deionized water was added. The suspension was incubated for another 15 
minutes and then centrifuged at 13000 × g for 15 minutes at 4 oC. The supernatant was 
analyzed for either β-lactamase or subtilisin activities using the same method as described 
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in whole-cells (see Section 2.2.5). The activity measured was assigned as the periplasmic 
activity (Block 6, Figure 2–2).  
2.2.7 Preparation of cell–free extract 
The pellets from the last step of periplasmic fraction preparation (Block 6, Figure 
2–2) were resuspended in 2 ml of 10 mM sodium phosphate buffer (pH 7.4) containing 5 
mM DTT (dithiothreitol). This was followed by ultrasonication (70 Watts output, 15 s × 4 
bursts with 45 s intervals). The supernatant was collected after centrifugation at 13000 × 
g for 15 minutes at 4oC and was analyzed for either β-lactamase or protease activity as 
described in 2.2.4 and 2.2.5. The activity was added to the periplasmic activity to obtain 
the cell-free extract activity (Block 8, Figure 2–2). 
2.2.8 Polymyxin B Nonapeptide Permeabilization 
PMBN treatment was conducted by pre-incubating the cells with 50 µg/ml PMBN 
for 5 minutes at room temperature before reaction.  
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2.3 Results 
Two outer membrane mutants with their respective isogenic parents were used in 
this study. One mutant, SM101, carries a mutation in the lipopolysaccharide (LPS) 
synthesis pathway (Table 2–1). In particular, the thermo-sensitive mutation occurs at 
lpxA, which encodes UDP-N-acetylglucosamine O-acyltransferase, the enzyme that 
catalyzes the first step of lipid A biosynthesis22. As a result of this mutation, both lipid A 
and lipopolysaccharide synthesis were significantly reduced.  At a permissive 
temperature (below 37 oC), the mutant produces 30% less lipid A than the control strain, , 
23. The reduced LPS synthesis is thought to be compensated by glycerophospholipid, 
resulting in a hybrid outer leaflet of the outer membrane.  Previously, the E. coli strain 
carrying this mutation was found to be particularly susceptible to hydrophobic antibiotics. 
The MICs (minimal inhibitory concentration) of a large number of antibiotics for the LPS 
mutant are 30– to–1000–fold lower than for its parent24. 
The other outer membrane mutant (E609L) used in this study carries a transposon 
mutation in a structural protein called Braun’s lipoprotein. The function of this 
lipoprotein is to maintain rigidness and integrity of the outer membrane by linking the 
inner leaflet of the outer membrane with the peptidoglycan (Figure 2–1A). As a result of 
the mutation, the cells were susceptible to chelating agents (such as ethylene diamine 
tetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA)), as manifested by a 
decrease in cell density OD600. Some leakage of proteins was also observed, 25.  
 Table 2–1 shows the four strains and two plasmids used in this study. In order to 
focus our study on outer membrane permeability, we used two plasmids that directed the 
23 
expression of two enzymes of interest into the periplasmic space. Plasmid pBR322 carries 
a gene coding for β-lactamase along with its signal sequence that allows secretion of the 
expressed enzyme to the periplasmic space. Plasmid pGES201 allows periplasmic 
expression of subtilisin, a serine protease.  
Mutant strains SM101, E609L and their respective isogenic parents were 
transformed with either pBR322 (β-lactamase) or pGES201 (subtilisin). No appreciable 
differences in growth behavior were observed between E609L and E609. SM101 grew 
slightly slower than SM105 (according cell density OD600 measurement), with a doubling 
time about 20% longer than the wild type grown at 28oC in LB medium. Whole cells of 
these transformants were prepared as described in the Experimental section. Enzyme 
activities were measured and were compared to the activities of periplasmic and cell 
extracts.  
The permeabilizing effect of polymixin B nonapeptide (PMBN) on whole cell 
reactions with nitrocefin and tetrapeptide was also studied. PMBN is a proteolytic 
product from the natural antibacterial peptide Polymixin B (PMB). PMBN, an extremely 
poor antimicrobial agent, is about 100–fold less toxic to E. coli cells than PMB, but is 
structurally similar to its parental compound and is still capable of binding to Lipid A. 
Consequently, PMBN is a good outer membrane permeabilizer for gram-negative 
bacteria26, 27.  
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2.3.1 Reaction with nitrocefin substrate 
Nitrocefin (MW = 516.5, Figure 2–3A) is a substrate for β-lactamase. Nitrocefin 
is a relatively hydrophilic molecule compared to the other substrate used in this study, the 
tetrapeptide (MW = 624.6, Figure 2–3B). The penetration of nitrocefin into the host cells 
is hindered by the presence of the outer membrane28. β-lactamase activities measured 
with nitrocefin as the substrate are tabulated in Table 2–2A. The activities of cell-free 
extract for all four constructs were similar, indicating a similar level of the β-lactamase 
expressions by each strain. Therefore, neither mutation in the outer membrane structure 
of the host cells significantly affects the ability of the cells to synthesize the recombinant 
enzymes. As well, the mutant cells maintained the ability to recognize and cleave the 
signal peptide sequence, and folded β-lactamase in the periplasm to its correct 
conformation.  
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Figure 2–3. A: Chemical structure of nitrocefin. B: Chemical structure of N-succinyl-
Ala-Ala-Pro-Phe-p-nitroanilide. 
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Notably, whole-cell activities are significantly lower than the activities of either 
the periplasmic fraction or the cell extract. The activities expressed as a percentage of the 
respective cell-free extract activities are tabulated in Table 2–2B.  Whole cells had only 
5%–to–20% of the cell-free extract activity, indicating the rate-limiting effect of the cell 
membranes. Since the enzyme is expressed in the periplasmic space, the main penetration 
barrier is the outer membrane (Table 2–2A and 2–2B). LPS mutation increased the 
activity of the whole cells from 0.088 to 0.13 Units/OD 600 Cell (Table 2–2A), or 
percentage activity increase from 13%–to–20%, (50% increase, Table 2–2B). An increase 
in the percentage activity from 5%–to–18% after lipoprotein mutation was also observed 
(a 3.8–fold increase). Although a measurable increase in the reaction rate accompanied 
each mutation, the permeability resistance of the outer membrane to nitrocefin still 
existed. 
 
Table 2–2A. β-lactamase activity. 
Activity (Units/OD600 cell)a 
Strains Whole-cell Periplasmic 
fraction 
Cell-free 
extract 
PMBN 
treated cells 
SM101/pBR322 0.13 ± 0.03 0.61 ± 0.06 0.63 ± 0.09 0.25 ± 0.03 
SM105/pBR322 0.09 ± 0.02 0.67 ± 0.12 0.68 ± 0.10 0.49 ± 0.06 
E609L/pBR322 0.12 ± 0.01 0.63 ± 0.09 0.63 ± 0.07 0.33 ± 0.07 
E609/pBR322 0.03 ± 0.01 0.69 ± 0.11 0.71 ± 0.11 0.59 ± 0.13 
 
a All results are averages of  at least three separate experiments and are represented as 
means ± 1 standard deviation. 
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Table 2–2B. Percentage β-lactamase activity. 
Percentage Activity 
(with respect to cell-free extract) 
 
Strains 
Whole-cell a PMBN treated cellsb
SM101/pBR322 20 39 
SM105/pBR322 13 71 
E609L/pBR322 18 52 
E609/pBR322 4.8 83 
 
a 100
2a) (Tableextract  free-cell ofActivity 
2a) (Table cell- wholeofActivity ×  
b 100
2a) (Tableextract  free-cell ofActivity 
2a) (Table cells treated-PMBN ofActivity ×  
 
Higher rates were observed when a peptide permeabilizer, PMBN, was employed. 
For PMBN-treated cells, percentage activities reached 40%–to–80% of the respective 
cell-free extract levels (Table 2–2B), indicating the importance of the Lipid A region as a 
permeability barrier. A comparison of whole cell activities with and without PMBN 
treatment is shown in Figure 2–4, a plot of activity ratios for treated and untreated cells. 
The effect of permeabilizing with PMBN is more pronounced for wild-type cells than for 
mutant strains. This is not surprising for the LPS mutant, as less Lipid A was synthesized 
in the mutant and, consequently fewer PMBN binding sites were available in the 
membrane. The reason for a greater effect on permeation of PMBN toward E609 
compared to E609L is not yet understood. 
Interestingly, the two wild-type strains (SM105 and E609) exhibited significant 
differences in whole-cell activities. E609 had an activity of 0.034 units, a result 2.6–fold 
lower than the activity of 0.088 units measured for SM105. This difference is not due to 
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the expression level of the enzymes, as both strains have a similar level of expression as 
judged by the activities in the cell-free extract. Rather, the difference may be attributed to 
the different outer membrane structures that result from their different genetic 
background. Particularly, if the Lipid A concentration in the outer membrane outer leaflet 
was significantly higher in E609 than SM105, one would expect to see lower whole-cell 
activities but more pronounced PMBN effects on permeability in E609. The observed 
activities are consistent with this hypothesis (Table 2–2 and Figure 2–4) but further 
confirmation of this explanation is desirable and should be addressed in future studies. 
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E609L/pBR322
SM105/pBR322
SM101/pBR322
Activity Ratio of Treated/Untreated Cells
1
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Figure 2–4. PMBN permeabilizing effect. Error bars represent standard deviations from 
the mean. All activities are averages of the results from at least three 
separate experiments. 
 
The Lipid A region is very hydrophobic and therefore suspect as the barrier for 
hydrophilic molecules such as nitrocefin. Accordingly, PMBN is highly effective in 
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increasing the outer membrane permeability to this substrate. Yet, reduction of Lipid A 
synthesis by LPS mutation is less effective for this purpose. This may be due to the 
hybrid outer membrane structure that results from LPS mutation. The reduced Lipid A 
may have been replaced with other hydrophobic lipid molecules by a compensatory 
mechanism, effectively diminishing the effect of reduced Lipid A in increasing 
permeability. Genetic modifications of the fatty-acid moiety of Lipid A may be more 
effective in reducing the resistance of the outer cell membrane to hydrophilic molecules 
(Figure 2–1B). 
2.3.2 Reaction with a tetrapeptide substrate 
We have also investigated the transport of the tetrapeptide N-succinyl-Ala-Ala-
Pro-Phe-p-nitroanilide (AAPF-pNA, Figure 2–3B) across the cell walls of our E. coli 
strains. To our knowledge, the outer membrane permeability to this substrate has not been 
investigated. In a previous study, whole cells with periplasmically-expressed subtilisin 
exhibited some activity, indicating some permeability through the outer membrane. 
However, the authors did not identify low cell-wall permeability as the rate-limiting step 
in the synthesis.  
The effect of mutations on the reaction rate of the tetrapeptide was investigated in 
the present study. Four strains (Table 2–1) were transformed with plasmid pGES 201, 
which carries a gene coding for subtilisin E. The expression of the enzyme is driven by an 
arabinose-inducible promoter. The majority of the enzyme activity was found in 
periplasmic space (Table 2–3A). Judging by the activity levels in cell-free extract, both 
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mutants had lower expression of the enzyme than the wild types. SM101 had an 
expression level about 15% lower than the parental strain and the expression level in 
E609L was about 25% lower than that in the wild type. Despite the lower expressions, 
mutant whole-cells exhibited activities either similar to (E609 pair) or significantly higher 
(SM pair) than the activities obtained by their respective parental stains (Table 2–3A, 
column 1), indicating increased permeability by either mutation.  
When whole-cell activities are compared with their respective cell-free extract 
activities, wild-type cells SM105/pGES201 and E609/pGES201 have about 46% and 
60%, respectively, of their associated cell-free extract activities. The existence of a 
permeability barrier to AAPF-pNA in each cell type is indicated.  Mutation of LPS 
increased the whole-cell activity to 95% of the cell-free extract level, or 105% of the 
periplasmic level. This result is particularly striking as it implies that the mutation 
rendered the whole-cells completely permeable to the tetrapeptide and eliminated the 
mass transport resistance.  Whole-cell catalysts reach a membrane-less or barrier-less 
condition that maximizes reaction rates. Lipoprotein mutation was also effective in 
increasing the permeability of the substrate. The reaction rates for whole-cells reached 
about 80% of their cell-free extract level or 94% of their periplasmic level. Thus, for this 
mutant, the mass transport limitation imposed by the outer membrane was almost totally 
eliminated.  
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Table 2–3A. Subtilisin activity. 
Activity (mUnits/OD600 cell)a 
Strains Whole-cell Periplasmic 
fraction 
Cell-free extract PMBN treated 
cells 
SM101/pGES201 3.9  ± 0.5 3.7  ± 0.3 4.1  ± 0.2 4.1  ± 0.4 
SM105/pGES201 2.2  ± 0.4 4.6  ± 0.4 4.8  ± 0.4 2.6  ± 0.3 
E609L/pGES201 6.7  ± 0.8 7.1  ± 0.8 8.1  ± 0.9 6.7  ± 0.7 
E609/pGES201 6.4  ± 0.7 10  ± 1.1 11  ± 1.2 6.9  ± 0.7 
 
a All results are averages of  at least three separate experiments and represented as means 
± 1 standard deviation. Activities are in milli-units. 
 
Table 2–3B. Percentage subtilisin activity. 
Percentage Activity 
(with respect to cell-free extract) 
Percentage Activity 
(with respect to periplasmic fraction)
 
Strains 
Whole-cella PMBN treated 
cellsb
Whole-cellc
SM101/pGES201 95 100 105 
SM105/pGES201 46 54 48 
E609L/pGES201 82 82 94 
E609/pGES201 59 64 66 
a 100
3a) (Tableextract  free-cell ofActivity 
3a) (Table cell- wholeofActivity ×  
b 100
3a) (Tableextract  free-cell ofActivity 
3a) (Table cells treated-PMBN ofActivity ×  
c 100
3a) (Tablefraction  Periplsmic ofActivity 
3a) (Table cell- wholeofActivity ×  
 
The PMBN permeabilizing effect was also investigated with tetrapeptide. The 
ratios of activities of treated cells to the activities of untreated cells are plotted in Figure 
2–4. The activity ratios for PMBN-treated cells relative to untreated cells are in the range 
of 1.0 to 1.2, indicating only a small reduction in the barrier to permeation for the 
tetrapeptide. This is expected for mutant strains, as they no longer experience any 
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hindrance to permeation through the outer membrane. However, the minimal effect of 
PMBN on wild-type strains is in sharp contrast with the results from studies with 
nitrocefin, for which the ratios fell in the range of 2–to–18 (Figure 2–4) and for which the 
more pronounced effect was observed for the wild type strains. The difference in 
hydrophobicity of the two substrates may be responsible for this observation. PMBN acts 
by binding to Lipid A of the LPS, the highly hydrophobic region of the outer membrane. 
Based on the solubility of nitrocefin in an aqueous solution that did not dissolve the 
tetrapeptide, we consider the tetrapeptide to be more hydrophobic than nitrocefin. 
Therefore, the tetrapeptide can be expected to permeate through the Lipid A region more 
quickly than does the nitrocefin. 
The LPS mutation and lipoprotein mutation do not cause detectable leakage of the 
β-lactamase or subtilisin under the conditions used for whole-cell activity assay. This was 
ascertained by measuring the respective activities of the supernatant samples taken during 
whole-cell reactions under identical experimental conditions. The supernatant showed 
negative β-lactamase or protease activity. Therefore, the increased whole-cell activity is 
attributable to increased permeability via mutations rather than to leakage of the enzymes. 
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2.4 Discussion 
The substrate permeation barrier presented by cell envelopes is the underlying 
cause of low whole-cell biocatalysis rates. In this study, significant acceleration of whole-
cell biocatalysis was achieved by reducing the barrier properties of the outer membrane 
via genetic modifications of the outer membrane structure. In the case of the tetrapeptide, 
mutation of the outer membrane accelerated the biocatalytic reaction to its maximum 
since the cellular membrane no longer impeded mass transport of the enzyme reactants. 
By using a single mutation, whole-cell biocatalysis exhibited the same rates as for free 
enzymes, yet all the advantages of whole-cell catalysis were preserved.  
For the nitrocefin reaction, however, the same mutations had less impact on 
increasing the whole-cell reaction rates and only about 20% of the achievable cell-free 
extract level was measured. The gains to be realized by mutating the outer membrane are 
therefore dependent on the nature of the substrate. The results of experiments using 
PMBN to increase substrate permeation rates indicate the importance of the relative 
hydrophobicities of the substrates. This explanation is consistent with the earlier studies, 
which showed that E. coli cells with an LPS mutation were particularly susceptible to 
hydrophobic antibiotics due to increased permeability. Other differences, such as the 
molecular size of substrates and their ability to carry an ionic charge, certainly contribute 
to the differences in mass transport rates across the genetic altered cell walls. 
To further probe the relationship of membrane permeability to the substrate 
molecular structure, the E. coli mutants could be interrogated with substrates of 
systematically varied sizes, hydrophobicities, and ionic charges. Other mutants, 
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engineered to allow passage of particular molecular structures, could also be developed. 
Understanding these relationships is important for predicting the effects of genetic 
modifications on catalysis rates and can ultimately lead to other rational approaches for 
modifying cellular membranes. This study was one step toward that goal. 
In the case of tetrapeptide, mutations of the outer membrane structure resulted in a 
significant increase in permeability, whereas treatment with PMBN had little effect. 
Modifying the membrane structure genetically was more effective in increasing the 
permeation rate of tetrapeptide, than was treatment with the permeabilizer, strongly 
supporting our rationale for pursuing genetic alterations as a means of improving whole-
cell biocatalysis rates. The PMBN treatments, however, identified the Lipid A region of 
E. coli as a potentially useful site for genetic modifications targeting increased 
permeability to hydrophilic molecules like nitrocefin. More importantly, the results 
presented here suggest that the genetic modification of Lipid A might be a better strategy 
than reducing the Lipid A content of the cell membrane. 
 CHAPTER 3 
Lipoprotein Mutation Accelerates Substrate-Permeability Limited Toluene 
Dioxygenase–Catalyzed Reaction 
 
 
 
One of the major problems in whole-cell biocatalysis is its low reaction rate. The 
underlying cause is the substrate permeation barrier presented by cell envelopes. The 
present research investigates mutation effects of the Braun’s lipoprotein, the most 
abundant outer membrane structural protein in E. coli, on toluene dioxyengase (TDO)-
catalyzed reaction. Dramatic enhancement of the reaction rate, an increase of up to six 
fold, was observed with the mutant for all three small, hydrophobic substrates tested 
(toluene, ethylbenzene and 2-indanone).  The increase was observed over a wide range of 
substrate concentrations (0.1–5 mM). The mutant exhibited the same growth rate and 
comparable recombinant multi-component enzyme expression level as the isogenic parent 
strain. Taken together, the lipoprotein mutant carrying a plasmid encoding TDO is a 
much better whole-cell catalyst for the oxidation reaction. The beneficial effect of the 
lipoprotein mutation may be general for a broad range of substrates and enzyme systems 
as the mutation affects the global integrity of the cell membrane.  A comparison of the 
mutation effect with a common permeabilizing procedure, the EDTA treatment, further 
illustrated the clear advantages of using genetic modification in cellular membrane 
engineering for improved whole-cell catalysts.  
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3.1 Introduction 
Toluene dioxygenase (TDO) is a multi-component enzyme system that catalyzes 
the dioxygenation of toluene to toluene cis-dihydrodiol. In addition to toluene, it accepts 
other aromatic compounds, non-aromatic nuclei and aliphatic olefins as substrates. It 
catalyzes not only dioxygenation, but also monooxygenation, desaturation, O 
dealkylation, N dealkylation, sulfoxidation, and oxidative dehalogenation reactions29,  30. 
Its remarkable versatility has stimulated numerous studies in recent years for potential 
applications in bioremediations of recalcitrant aromatic hydrocarbons such as toluene and 
related compounds, and for chiral synthon synthesis in green chemistry applications31, , 
, , , , 
32
33 34 35 36 37.  
So far, the studies of application of TDO have been exclusively with whole-cell 
catalysts. This is not surprising as the oxidation involves multiple enzyme components 
reductase, ferredoxin and terminal dioxygenase, and requires cofactor NADH. It would 
be too complicated if each component of the system were to be isolated and reconstituted 
in vitro. However, one obstacle in applying such whole-cell biocatalysts is the limited 
substrate permeability imposed by the cell envelopes, which could result in reduced 
reaction rate and low productivity 
Toluene is a small hydrophobic molecule. In general, the outer membrane of 
gram-negative cells such as E. coli, especially the outer leaflet that consists of 
lipopolysaccharides (LPS), is a formidable barrier for hydrophobic molecules. The LPS 
monolayer is a highly ordered quasi-crystalline structure with very low fluidity, which 
does not allow rapid diffusion of molecules.  Additional rigidity of the outer membrane 
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can be attributed to its interaction with the murein layer involving an outer membrane 
lipoprotein, called Braun’s lipoprotein. This protein is present in some 700,000 copies per 
cell, which makes it the most abundant protein in numerical sense in E. coli. About one-
third of the lipoprotein molecules are covalently linked to murein and help hold the two 
structures together. Mutants defective in the structural gene for this protein are fully 
viable, indicating it is nonessential. However, it is possible the disruption of lipoprotein 
will affect the global membrane integrity and thus may effect some changes in substrate 
permeability. Indeed, our earlier studies have found that the permeability for nitrocefin 
and a tetrapeptide, substrates for a β-lactamase and a protease, respectively, through the 
outer membrane were increased in a mutant which was absent of a major lipoprotein. 
Consequently, reaction rates catalyzed by the respective enzymes were dramatically 
increased with the mutant cells38. It was not clear, though, how the mutant would fare 
with smaller but very hydrophobic molecules. In this study, we examined the mutation 
effect of lipoprotein on reaction rates catalyzed by TDO. Exploiting the relaxed substrate 
specificity of this enzyme system, we investigated TDO catalyzed reactions with three 
different substrates, toluene, ethylbenzene, and 2-indanone. To fully assess the suitability 
of the mutant as a whole-cell catalyst, a comparison study of cell growth and level of 
recombinant protein production was also carried out.  
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3.2 Experimental 
3.2.1 Reagents, bacterial strains and plasmids 
All chemicals were reagent grade and used as received. Toluene, o-cresol, 
ethylbenzene, 2-ethylphenol, 2-indanone, ethyl acetate, and butyl acetate were purchased 
from Aldrich (St. Louis, Mo). Isopropyl-β-D-thiogalactopyranoside (IPTG) was 
purchased from BioVectra (Canada). cis-(1S,2R)-Dihydroxy-3-methylcyclohexa-3,5-
diene (cis-toluene dihydrodiol) was purchased from CSS (Northern Ireland). Ready Tris-
HCl gel, Laemmli sample buffer, 2-mercaptoethanol, SDS-PAGE Low Range Molecular 
Weight Standards and Coomassie Brilliant Blue R-250 stain and destain solution were 
purchased from Bio-Rad (Hercules, CA).  
Plasmid pDTG601, which was constructed by inserting gene todC1C2BA into 
pKK223-3 for TDO expression under the control of the tac promoter, was a gift from Dr. 
D. T. Gibson39. Two E. coli host strains were used in this study. E609L, in which the 
gene lpp encoding Braun’s lipoprotein was disrupted by a Tn10 insertion, is designated as 
the mutant. E609 was its isogenic parent and was used as the control. Strains 
E609L/pDTG601 and E609/pDTG601 were constructed by transforming the host strains 
with plasmid pDTG601.  
3.2.2 Cell growth curve and protein expression 
LB medium supplemented with appropriate antibiotics (as described below) was 
used in all cultivations. The medium for plasmid-carrying strains was supplemented with 
38 
100 µg/ml ampicillin and the medium for the mutant was additionally supplemented with 
12.5 µg/ml tetracycline.  For cell growth study, 100 ml of medium in a 500 ml flask was 
inoculated with an overnight culture of E609L, E609, E609L/pDTG601, and 
E609/pDTG601 (2% inocula). The flasks were shaken in a rotary shaker at 250 rpm at 37 
oC. Samples were taken from each culture every hour to monitor the growth pattern by 
measuring optical density at 600 nm with a UV/VIS spectrophotometer (Lambda 40 
Spectrometer, Perkin Elmer). For cell growth study with induction, the same medium as 
described above was used and initial cultivation was carried out at 37oC until OD600 
reached 0.5–0.7, when IPTG was added to a final concentration of 1 mM and the 
cultivation temperature was shifted to 30 oC.  
To evaluate the TDO expression levels by SDS-PAGE analysis, samples were 
taken every hour for four hours after induction. Whole-cells pellets from 1 ml culture 
were suspended in 100 µl 1 × SDS-PAGE sample buffer containing 2.5% 2-
mercaptoethanol. Samples were boiled for 5 minutes and centrifuged briefly. 5 µl of 
samples and a marker were loaded into a Ready 10 % Tris-HCl gel (6.8 cm × 8.6 cm, 1.0 
mm thickness). The gel was stained using Coomassie Brilliant Blue R-250 stain solution. 
3.2.3 Initial velocity measurement 
Ten ml of LB medium supplemented with 100 µg/ml ampicillin in a 50 ml flask 
was inoculated with an overnight culture of E609L/pDTG601 or E609/pDTG601 (2% 
inocula). Other cultivation and induction conditions were as described in the cell growth 
studies. 
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 Two hours after induction, 1 ml of culture was collected in a 1.5 ml Eppendorf 
tube. Cells were harvested by centrifugation at 4,000 × g for 10 minutes at 4oC and 
washed once with 10 mM sodium phosphate buffer (pH 7.4). Cell pellets were collected 
by centrifugation and resuspended into 0.5 ml of same sodium phosphate buffer 
containing 0.4% glucose. The reaction was started by addition of substrate to a desired 
final concentration. The reaction mixture in the Eppendorf tube was then sealed with 
parafilm and shaken at 250 rpm at 37oC for 15 minutes for initial rate measurement. The 
product of the oxidation reaction was extracted by ethyl acetate. In the case of reactions 
with toluene and ethylbenzene, before subject to GC analysis, the products were 
dehydrated to their respective dihydrodiol products by an acid treatment (25 µl of 2M 
HCl) (Figure 3–1)40. The extract was analyzed by a Hewlett-Packard GC/MS system. All 
activities were normalized by A600 to correct for small differences in cell density between 
preparations.  
3.2.4 Time course  
The time course of the whole cell catalyzed reactions was conducted under the 
same conditions as described above, except that the reaction was allowed to proceed to a 
longer period of time and samples were taken from time to time to monitor the progress 
of the reactions.  
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3.2.5 Analytical methods 
Samples as prepared above were analyzed using a Hewlett-Packard 6890 (Palo 
Alto, CA) Gas Chromatograph equipped with an MSD, an autosampler, and an injector. 
A HP-5MS methylpolysiloxane phase column (30 m × 0.25 mm × 0.25 µm) was used. 
The temperature for the injector and the MSD was 280 oC. Column temperature profile 
was according to a pre-determined program (40oC for 1 minute, first temperature gradient 
to 180oC at 10 oC/min; second temperature gradient to 300oC at 25 oC/min; and holding 
the final temperature for 10 minutes). The flow rate of the carrier (He) was 1 ml/min. 
Under these conditions, the retention times for butyl acetate (internal standard), toluene, 
o-cresol, ethylbenzene, 2-ethylphenol, 2-indanone and (S)-2-hydroxy-1-indanone were 
4.46, 3.99, 7.90, 5.17, 9.17, 7.10 and 12.55 min, respectively.  
3.2.6 EDTA treatment 
 The effect of EDTA on whole-cell catalyzed-reaction rate was studied. EDTA 
was added to a cell suspension to a final concentration in the range of 0.1 to 1.0 mM. The 
mixture was incubated quiescently at room temperature for 15 minutes before 2 mM 
toluene was added. The reaction was carried out under the conditions as described above.  
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3.3 Results 
In order to evaluate the mutation effect of lipoprotein on TDO catalyzed reactions 
and the suitability of lipoprotein mutant as whole-cell catalyst in bioremediation and 
green chemistry applications, we used three different TDO substrates in this study, 
toluene, ethylbenzene, and 2-indanone. The respective reactions and products are 
illustrated in Figure 3–1.  E. coli strain E609L carries a transposon mutation in an outer 
membrane structural protein called Braun’s lipoprotein, and E609 is its isogenic parent 
and is used here as the control. The two strains were transformed with a plasmid 
pDTG601, which harbors the genes of TDO from Pseudomonas putida F1, a multi-
component system. 
3.3.1 Cell growth and recombinant protein expression  
 One essential attribute for microbial whole-cell biocatalysts is their ability to grow 
and attain high cell density. In the process of engineering a whole-cell biocatalyst, one 
important consideration is to balance the need for increased permeability of substrate 
with the need for the cell to maintain sufficient membrane functions and to retain the 
ability for growth as much as possible. Since the membrane function is critical to cell 
growth, any mutation aimed to increase the substrate permeability should be evaluated 
with respect to the effect on cell growth. We therefore carried out a comparison study to 
evaluate the lipoprotein mutation on cell growth. 
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Figure 3–1. Oxidation reactions catalyzed by toluene dioxygenase. (A) toluene, (B) 
ethylbenzene, (C) 2-indanone. 
 
The mutant and control were grown in shaker flasks under identical conditions 
except that for the mutant, the LB medium was supplemented with tetracycline in order to 
apply a selective pressure for the transposon insert. As shown in Figure 3–2A, the two 
strains exhibited, in the first seven hours of cultivation, an almost identical growth rate 
with doubling time of 0.96 hour. After seven hours, the growth rates were reduced, but 
more so with the mutant strain, resulting in a difference in cell concentrations about 10%. 
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The highest cell concentrations reached were 3.1 and 3.4 OD600 for the mutant and the 
control, respectively.  
Similar growth behaviors were observed when cell growth studies were carried 
out with the two strains carrying plasmid pDTG601 but without induction (Figure 3–2B). 
The only difference observed in growth was in the last few hours of cultivation. The 
highest cell concentrations reached were 2.6 and 3.0 OD600 for the mutant and the control, 
respectively, both lower than what were obtained without the plasmid, reflecting the extra 
burden of maintaining an 8.6 kb plasmid. The difference in cell density between the two 
strains was similar with or without plasmid (0.4 versus 0.3).  Therefore, the mutation 
does not dramatically affect the cell’s growth yield when carrying the plasmid. However, 
the mutant did not seem to be able to maintain the highest cell density obtained and there 
was a decrease of OD as soon as the highest density was reached, unlike the case without 
the plasmid and with the control (Figure 3–2A), suggesting that the presence of the 
plasmid made the mutant cells somehow vulnerable and the cells were on the verge of 
death (or lysis) at the end of the growth period. 
Growth comparison was also conducted for the two strains carrying pDTG601 
with inductions. As shown in Figure 3–2C, for many hours after induction, mutant cells 
were able to grow at the same rate as the parent strain. This is consistent with the results 
from Figure 3–2B without induction, but surprising considering that as soon as the 
growth stopped, the cell death (or lysis) ensued as manifested by the decrease of the OD.  
The parent strain, however, maintained the highest cell density in the stationary phase. 
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Consequently, after the cessation of the growth, the difference in cell concentrations was 
widened from about 0.4 at 9th hour to about 0.6 at 12th hour.  
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Figure 3–2. Growth pattern of (A) E609L (▲) and E609 (■); (B) E609L/pDTG601 (▲, 
without induction) and E609/pDTG601 (■, without induction); (C) 
E609L/pDTG601 (▲, IPTG induction) and E609/pDTG601 (■, IPTG 
induction). Error bars represent standard deviations from the mean. All data 
are measured in at least three separate experiments. 
 
Taken together, the lipoprotein mutation does not seem to affect the growth rate 
even when cells are carrying a plasmid and are producing recombinant proteins. 
However, the mutation apparently sensitizes the cell to conditions that are typically found 
at the end of growth, or in stationary phase. We speculate that limitations of nutrients and 
accumulation of waste products such as acetate may be responsible for the difference 
observed at the end of the cultivation. Further study is needed to fully understand the 
underlying reasons for the phenomenon observed.  
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Figure 3–3. SDS-PAGE comparison of the toluene dioxygenase expression in E. coli 
E609L/pDTG601 and E609/pDTG601. The cellular fractions were loaded 
on the gel as follows: 1 hr induced E609L/pDTG601 (lane 1), 1 hr induced 
E609/pDTG601 (lane 2), 2 hr induced E609L/pDTG601 (lane 3), 2 hr 
induced E609/pDTG601 (lane 4), 3 hr induced E609L/pDTG601 (lane 5), 3 
hr induced E609/pDTG601 (lane 6), 4 hr induced E609L/pDTG601 (lane 
7), 4 hr induced E609/pDTG601 (lane 8).  
 
 Since engineered whole-cell catalysts with overexpression of one or more 
recombinant enzymes are common in biocatalysis, another essential attribute of the 
whole-cell catalyst is the ability for high level expression of recombinant proteins. For 
this reason, we carried out studies to compare the expression levels of TDO for the two 
strains. Samples were taken every hour after induction for four hours, and expression 
levels were evaluated using SDS-page gel and Coomassie Blue stains. Figure 3–3 shows 
that there is essentially no detectable difference in expression levels of TDO between the 
two strains for all the samples (1–4 hours after induction) analyzed and for all 
components of the TDO system. Therefore, the mutation in lipoprotein does not affect the 
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expression of the multi-component TDO system. Samples taken after 4 hours exhibited 
lower activities for reasons not clear to us, but this is the case for both strains and 
therefore is not an effect associated with the mutation. In subsequent catalysis studies, 
conditions (2 hrs after induction) that gave rise to comparable expression levels of TDO 
in two strains were used.  
3.3.2 Lipoprotein mutation on initial velocity 
The initial velocities for the oxidation reactions catalyzed by the two recombinant 
strains were measured for substrate concentrations over the range of 0.1-5 mM. As shown 
in Figure 3–4A, B, and C, the mutant strain exhibited much higher initial activities for 
each of three substrates and at all substrate concentrations tested, suggesting a positive 
effect of mutation on increasing reaction rate. The difference in the initial velocity was 
not due to the difference in expression as comparable level of expression was achieved 
(as discussed earlier). Although some of the components of TDO are inner membrane 
bound and some reside intracellularly, toluene, ethylbenzene, and 2-indanone are 
sufficiently hydrophobic and their passage through inner membrane is not expected to be 
rate-limiting. The increased initial reaction rate is therefore likely through improved outer 
membrane permeability to substrates due to the mutation.  
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Figure 3–4. Effect of substrate concentration on the initial degradation rate by whole- 
cell E. coli E609L/pDTG601 (▲) and E609/pDTG601 (■). (A) toluene, (B) 
ethylbenzene, (C) 2-indanone. Error bars represent standard deviations 
from the mean. All data are measured in at least three separate experiments. 
 
Over the range of toluene concentration tested, the initial rate ratios of mutant to 
parent strains varied over a range of 1.5 (at 0.1 mM) to 3.9–fold (at 5 mM). The initial 
velocity profile was complicated by the presence of possible substrate and/or product 
inhibitions, evident from the decline of the reaction rate with the increase of the toluene 
substrate concentrations (1-5 mM) for the parent strain. The mutant strain seemed to fare 
better in terms of inhibition and only a slight decrease of reaction above substrate 
concentration of 4 mM was evident (Figure 3–4A).  
For the second substrate, ethylbenzene, the initial velocity-substrate concentration 
profile was similar to that of toluene except that there was a sharp decline of enzyme 
activities at high substrate concentrations for both strains. The ratio of reaction rates of 
the two strains fall in the range of 1.8 (at 0.1 mM) and 6.3 (at 5 mM).  The reasons for the 
difference between the two substrate, with respect to possible substrate or/and product 
inhibitions, were not clear, and were not investigated further as it was deemed to be 
beyond the scope of this work.  
For 2-indanone (Figure 3–4C), the mutant strain had a substantially higher 
reaction rate than that of the parent over the entire range of concentrations examined. For 
example, at substrate concentration of 5 mM, the initial reaction rate of the mutant strain 
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is about 5 times of that of the parent strain. There was apparently no inhibition for this 
substrate.   
A departure of the enzyme kinetics from the Michaelis-Menten model was evident 
from inspection of Figure 3–4 and Eadie-Hofstee plots (Figure 3–5, shown only for 
toluene). This may be due to the multi-component nature of the system and the presence 
of inhibitions in the case of toluene and ethylbenzene. 
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Figure 3–5. Eadie-Hofstee plots of whole-cell enzyme kinetic properties of 
E609L/pDTG601 (▲) and E609/pDTG601 (■). 
 
3.3.3 Time courses of TDO catalyzed reactions 
Additional experiments were carried out to further evaluate the potential of the 
lipoprotein mutant as whole-cell biocatalyst in bioremediation and green chemistry 
applications. Time course of product formation from toluene degradation for initial 
toluene concentration of 2 mM is shown in Figure 3–6. Within 2 hours, the mutant 
converted 2 mM toluene to 1.5 mM product cis-dihydrodiol, which subsequently 
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chemically converted to o-cresol under acidic conditions, a conversion of approximately 
75%, whereas the parent strain had a conversion only about 30% and the product 
concentration reached was about 0.6 mM.  For reasons not clear to us, the reactions for 
both strains completed within about two hours and there was no further reaction beyond 
that. The observed difference in conversion and product concentration was a result of 
substantial difference in the reaction rate between the two strains, reflected by the 
difference in the slopes of the time course (Figure 3–6), a result consistent with the 
observed faster initial velocity (Figure 3–4A) for the mutant. Substantial differences in 
conversion and product concentration were also observed when different initial toluene 
concentrations were used. In all concentrations tested, the mutant degraded more toluene 
and achieved higher product concentrations. At an initial concentration of 1 mM toluene, 
for example, nearly 100% toluene was degraded by the mutant while the parent could 
only degrade about 50% (data not shown).  
 Similar results were obtained with other two substrates (data not shown). The 
product concentration formed with the mutant cells was 2-3 times higher than that 
obtained with the parent strains, a result that correlated well with the initial velocity 
differences between the two strains (Figure 3–4).  
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Figure 3–6. Time course of toluene degradation by whole-cell E. coli E609L/pDTG601 
(solid) and E609/pDTG601 (open). Initial toluene concentration was 2 mM. 
Error bars represent standard deviations from the mean. All data are 
measured in at least three separate experiments. 
 
3.3.4 EDTA Treatment versus Lipoprotein Mutation 
EDTA is an effective membrane permeabilizer. It has long been used to treat 
bacterial cell membranes to increase permeability41. It functions through chelation of 
metal ions such as Ca++ and Mg++, which cross-link lipopolysaccharides, consequently 
adding to the rigidity of the outer membrane. Since the LPS layer is suspected to be the 
main permeability barrier to hydrophobic molecules such as toluene, removal of these 
metal ions is expected to weaken the intra-molecular interaction of LPO and loosen up 
the outer membrane layer, thus allowing passage of hydrophobic molecules through the 
outer membrane layer at a higher rate.  
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We carefully studied conditions of treatment, and under optimal conditions (0.5 
mM EDTA and a treatment time of 15 minutes), pretreatment with EDTA increased 
reaction rate with toluene about 23% (standard deviation 5%) for the parent strain E609 
(Figure 3–7). This compares with the lipoprotein mutation that increased the reaction rate 
more than two fold (Figure 3–7, Figure 3–4A), indicating the mutation in envelope 
structure could be far superior to chemical treatment.  Increasing EDTA concentration 
higher than 0.5 mM caused a decrease of TDO activities, probably due to the removal of 
the required metal cofactors for TDO (Fe++) and the destabilizing of the inner membrane. 
This result further illustrates that the chemical treatment causes undesired, generalized 
damaging effects that go beyond permeabilizing. 
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Figure 3–7. Effect of EDTA on the permeability of E609L/pDTG601 and 
E609/pDTG601. Error bars represent standard deviations from the means. 
All data are measured in at least three separate experiments. 
 
Interestingly, no increase in reaction rate by EDTA was observed for the mutant 
strain. The treatment, in fact, caused a sharp decrease of TDO activities (Figure 3–7). 
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This is probably due to the defect in membrane structure caused by the lipoprotein 
mutation that sensitizes the cells for EDTA treatment. 
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3.4 Discussion 
We have demonstrated that mutation in an outer membrane structural lipoprotein 
resulted in a several fold increase in the TDO-catalyzed reaction rate with the three small 
hydrophobic substrates investigated. The substantial increase in reaction rate indicates 
that modification of cellular membrane composition and mass transfer barrier properties 
through genetic engineering could be an effective method of accelerating whole-cell 
biocatalysis.  
The significant acceleration of the oxidation reaction implies that the defect in 
membrane structures caused by the lipoprotein mutation may be extensive. Yet 
remarkably, the mutant cells grow as fast as the parent strain, even under stressful 
conditions such as carrying a medium-sized plasmid and overproducing a four-
component recombinant enzyme system. It seems that the mutant cells were able to 
compensate the defect in membrane by some unknown mechanisms.  The defect may 
affect the energetic state of the membrane, the proton gradient, for example. If this is true, 
it is conceivable that the mutant cells can compensate the loss of proton gradient by 
metabolizing more of an energy source, which would lead to a lower growth yield. 
Consistent with this explanation, we observed a slightly lower growth yield for the 
mutant in all three cases investigated.  The mutant cells appear to be sensitive towards the 
end of the growth period, indicated by the loss of its ability to maintain cell biomass and 
an immediate transition to cell death phase when carrying a plasmid. The exhaustion of 
an energy source, which mutant cells are relying on to maintain the membrane energetic 
state and compensate the defect, could be responsible for the observed behavior at the end 
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of the cultivation. If this proves to be true, some additional carbon source would be 
sufficient to curb the loss of the biomass. Thus the difference in growth behavior caused 
by the mutation may not be a serious obstacle in biocatalysis applications, especially 
considering the difference is rather small and the gain in rate increase is substantial. 
 We have shown in this study that even with small molecules (molecular weight 
less than 100 Daltons), the substrate permeability can severely limit the reaction rate.  A 
full evaluation of the permeability barrier was not possible as attempts to remove the cell 
membrane barrier and reconstitution of TDO components in vitro failed to recover a 
majority of the enzyme activity.  However, from the dramatic acceleration by disruption 
of a structural protein, the severe limitation in substrate transfer across cell membrane can 
be appreciated. This common problem in whole-cell biocatalysis has been under-
addressed, and we hope our research and the encouraging results we presented here will 
stimulate interest in this important area.  
 The genetic modifications on membrane structure with lipoprotein mutation, as 
shown here and in an earlier work, brought about significant increases of several fold in 
the reaction rate with three enzyme systems (including simple hydrolases and a multi-
component redox enzyme system), and five substrates encompassing different sizes and 
different hydrophobicities. It appears that the beneficial effect on the whole-cell catalysis 
rate of the particular mutation is general.  
 CHAPTER 4  
Outer Membrane Mutation Effects on UDP–Glucose Permeability and Whole-Cell 
Catalysis Rate 
 
 
In whole-cell biocatalysis, cell envelopes represent a formidable barrier for 
substrates to permeate. As a result, the reaction catalyzed by the whole-cells is often 
orders of magnitude slower than that of their isolated enzyme counterparts. The present 
research addresses this critical issue by investigating the effects of outer membrane 
mutation on UDP-glucose utilizing enzymes in whole-cell systems. Owing to the severe 
limitation in substrate permeability, the wild type cells only exhibited as low as 4% of 
available enzyme activities. Reducing the barriers of the outer membrane permeability 
(by mutations in its structure) led to a striking acceleration (up to 14–fold) of reaction rate 
in cells expressing UDP-glucose dehydrogenase. Mutations in the lipopolysaccharide 
synthesis pathway or Braun’s lipoprotein are both effective. The acceleration was 
dependent upon the substrate concentrations as well as the enzyme expression level. In 
addition, the mutation has been demonstrated to be much more effective than the freeze-
thaw (FT) permeabilizing method. An application of outer membrane mutants was 
illustrated with the synthesis of a disaccharide (N-acetyllactosamine) from UDP-glucose. 
Both reaction rate and product yield were enhanced significantly (more than two fold) in 
the lipoprotein mutant, demonstrating the importance of the outer membrane permeability 
barrier and the advantages of using outer membrane mutants in synthesis.  
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4.1 Introduction 
Whole-cell biocatalysis allows more complicated biotransformation that requires 
multi-enzymes or even multi-pathways. Enzymes enclosed inside and protected by the 
cell envelopes are often more stable than their isolated counterparts. Moreover, whole-
cells provide what is often the only economically feasible way to regenerate expensive 
cofactors. However, whole-cell catalysts suffer a major problem. The cell envelopes 
represent a formidable barrier for substrates to permeate. As a result, the reaction 
catalyzed by the whole-cells is often orders of magnitude slower than that of the isolated 
enzymes.   
Until recently, the only effective way to address this was to permeabilize cells by 
chemical (such as detergent, solvent, and chelators) or physical (such as extreme 
temperature fluctuations) treatment. These methods are not desirable, especially for large 
scale applications, since they create additional steps in manufacturing processes, 
complicate downstream processing, and incur unintended damage to cells. Previously, we 
demonstrated that modifications in cellular membrane structure through a molecular 
engineering approach could be very effective in reducing the permeability barriers, 42. 
Some benefits of this approach are that the modification to the cell membrane structure is 
localized and effects on cell growth are minimal.  
In this chapter, we report a permeability study of a relatively large and 
hydrophilic molecule, UDP-glucose, using E. coli cells that express recombinant UDP-
glucose utilizing enzymes. The results reveal a severe limitation in permeability for this 
molecule and a striking acceleration of reactions by single mutations in membrane 
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structure. Also, the application of these mutants is illustrated with the synthesis of a 
important disaccharide, N-acetyllactosamine (LacNAc). LacNAc is one of the most 
common core structures in oligosaccharides of glycoproteins, some of which are 
significantly elevated in various types of cancer patients43 , 44 . LacNAc also play an 
important role in the initial event in many inflammatory responses45. The widespread 
biological role of LacNAc-based oligosaccharides has led to an increased demand for 
these structures for biomedical studies, and therefore, simple and efficient synthetic 
routes to these compounds are desirable. Compared to tedious chemical approaches 
(involving multiple protection and deprotection steps)46,47, the enzymatic preparation of 
these structures using glycosyltransferases is highly efficient, and has been applied in 
gram-scale production48. In this study, the product yield of LacNAc was increased using 
membrane mutant strains. Also, important implications of the permeability issues in 
whole-cell biocatalysis research are discussed. 
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4.2 Experimental 
4.2.1 Chemicals and reagents 
All chemicals were reagent grade and used as received. UDP-glucose (UDP-Glc), 
NAD, UDP-glucuronic acid (UDP-GA), N-acetyl-D-glucosamine (GlcNAc), N-acetyl-D-
lactosamine (LacNAc), isopropyl-β-D-thiogalactopyranoside (IPTG), and dithiothreitol 
were purchased from Sigma (St. Louis, Mo). Primers were from Invitrogen (Carlsbad, 
CA). Ready Tris-HCl gel, Laemmli sample buffer, 2-mercaptoethanol, SDS-PAGE low 
range molecular weight standards, Coomassie Brilliant Blue R-250 stain, and destain 
solution were purchased from Bio-Rad (Hercules, CA).  
4.2.2 Bacterial strains and plasmids 
The E. coli strains and the plasmids used in this study are listed in Table 4–1. Two 
types of E. coli membrane mutant strains were used in this study. The lipid A mutant 
SM101(lpxA2) is a thermo-sensitive, UDP-N-acetylglucosamine acyltransferase (lpxA) 
defective strain49. SM105 is its isogenic parent strain. E609L carries a Tn10 insertion in 
lpp coding for Braun’s lipoprotein. E609 is its isogenic parent. 
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Table 4–1. E. coli strains and plasmids used in this study.   
Strain or Plasmid Description Reference 
E. coli strains   
SM101 lpxA2 mutant, thermosensitive, grows well at 
28oC 
 
,  
SM105 lpx A2+, isogenic parent of  SM101 49,  
E609L lpp::Tn10; periplasmic leaky; Tcr ,  
 
E609 HfrC pps, isogenic parent of E609L 18,  
E609L(∆lacZ) E609L with deleted lacZ gene on chromosome This study 
E609(∆lacZ) E609 with deleted lacZ gene on chromosome This study 
 
E.coli O12:K5(L) ATCC 23508  ATCC 
Plasmids   
pCW-lgtB ampr, containing β-1,4-galactosyltransferase 
gene 
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pLysTE7 ampr, containing E. coli UDP–galactose 4-
epimerase. 
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pGEM-T-Easy 
vector 
ampr Promega 
pQE80L commercial expression vector from Qiagen 
containing T5 promoter and lacIq
Qiagen 
pBBR122 gram negative broad host vector  MoBiTech 
pT-GalE containing galE gene with Bgl II, Bam H I site This study 
pT-LgtB lgtB gene containing Bam H I and XhoI sites This study 
pT-EL ampr containing galE:lgtB with Bgl II XhoI 
sites 
This study 
pQEL ampr with T5 drive galE:lgtB fusion expression This study 
pT-KfiD ampr, containing KfiD gene This study 
pQEkfiD UDP-glucose dehydrogenase gene kfiD in 
pQE80L 
This study 
pCEL T5 directed β-1,4-galactosyltransferase 
(lgtB)/UDP-galactose 4-epimerase (galE) 
fusion protein encoding plasmid 
This study 
 
 
pKD13 template plasmid 52
pKD46 phage λ Red recombinase helper plasmid 52 
pCP20 FLP recombinase elimination helper plasmid 52 
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4.2.3 Construction of lacZ knockout strains 
The strains E609L(∆lacZ) and E609(∆lacZ) were constructed for LacNAc 
production using the gene inactivation method developed by Wanner and coworkers52. 
The FRT-flanked kanamycin resistance gene was PCR amplified along with a 50–
nucleotide extension at each end, which is homologous to the adjacent regions of the 
genomic lacZ gene. The PCR product was generated using plasmid pKD13 as the 
template and the following primers:  the 5’ primer, 5’-
GCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCGT
GTAGGCTGGAGCTGCTTC-3’) and the 3’ primer, 5’-
TTAAATAGTACATAATGGATTTCCTTACGCGAAATACGGGCAGACATGGCAT
TCCGGGGATCCGTCGACC-3’ (homologous regions underlined). Subsequently, the 
purified PCR product was introduced by electroporation into the target strains E609L and 
E609, which were carrying Red helper plasmid pKD46. Homologous recombination 
mediated by the plasmid-borne (pKD46) phage λ Red recombinase resulted in kanamycin 
resistant transformants. The kanamycin gene was then excised by introducing the FLP 
helper plasmid, pCP20, harboring the gene for FLP recombinase. Finally, both the Red 
helper plasmid and the FLP helper plasmid were cured by growth at above 37°C as they 
contain temperature-sensitive replicons.  
4.2.4 Construction of pQEkfiD, a T5 driven KfiD expression vector 
 The UDP-glucose dehydrogenase gene, kfiD53, was amplified from the genomic 
DNA of E. coli O12:K5(L) (ATCC 23508) with the primers designed according to the 
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kfiD sequence (GenBank accession #: X77617). The 5’ primer (5'-
TGGAGATCTATGTTCGGAACACTAAAAATAACTG-3') is a 34-mer that includes a 
Bgl II site (bold italics) and ATG start codon (bold underlined).  The 3’ primer (5'-
TTCTCGAGTTAGTCACATTTAAACAAATCGCGAC-3') is also a 34-mer with a Xho 
I site (bold italics) and stop codon TAA (shown its reverse complementary sequence, 
underlined). The 1.1 kb fragment was first inserted into the pGEM T-easy vector 
(Promega) to give pT-kfiD. Then the final expression vector pQEkfiD was constructed by 
inserting the kfiD gene, obtained from pT-kfiD by the double digestion by Bgl II and Xho 
I, into the BamHI and SalI site of pQE80L (Qiagen).  The organization of the plasmid 
pQEkfiD is shown in Figure 3–1A. 
4.2.5 Construction of pCEL, a T5 driven galE: lgtB fusion expression vector  
  The E. coli UDP-galactose 4’-epimerase gene was amplified from pLysPTE7 
using the following primers. The 5’ primer, 5'-
TGGAGATCTATGAGAGTTCTGGTTACCGGTGGT-3’, contains a Bgl II site (in bold 
italics) and start codon, ATG (underlined); the 3’ primer, (5'-
TAGGATCCGCCAGCGCTGAATCGGGATATCCCTGTGGATG-3’) contains a BamHI 
site (shown in bold italics) with the original stop codon, TAA, mutated to Ser codon 
TCA, (reverse complementary sequence underlined) and a mini-linker sequence, coding 
for a linker peptide, Ala-Ala-Gly-Gly-Ser. The PCR fragment, about 1 kb, was ligated 
into the pGEM T-easy vector to give the plasmid pT-GalE. The gene for β-1,4-
galactosyltransferase from Neisseria meningitidis, was cloned from a plasmid pCW-lgtB 
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with the following primers. The 5’ primer, (5'-
TAGGATCCATGCAAAACCACGTTATCAGCTTAG-3’), contains a BamHI site (bold 
italics) and start codon ATG (underlined); the 3’ primer, (5'-
TACTCGAGTTATTGGAAAGGCACAATGAACTG-3'), contains an Xho I site (bold 
italics). The amplified PCR fragment (about 0.8 kb) was inserted into the pGEM T-easy 
vector to give the plasmid pT-lgtB. The lgtB gene fragment, obtained from pT-LgtB by 
the double digestion by BamHI and SacII, was inserted into the same sites in pT-GalE 
downstream from galE to give pT-EL. The fusion gene fragment obtained by Bgl II and 
Xho I digestion was fused into the BamHI and SalI sites of pQE80L to give pQEL.  The 
plasmid pCEL was obtained by inserting the entire XhoI-hydrolyzed broad range host 
plasmid pBBR122 into the XhoI site of the pQEL. The organization of the plasmid pCEL 
is shown in Figure 3–1B. 
4.2.6 Expression of UDP-glucose dehydrogenase and GalE-LgtB fusion protein in E. 
coli 
The LB medium supplemented with appropriate antibiotics (as described below) 
was used in all cultivations. The medium for pQEkfiD carrying strains was supplemented 
with 100 µg/ml ampicillin and the medium for pCEL carrying strains was supplemented 
with 100 µg/ml ampicillin and 25 µg/ml chloramphenicol. All medium for the E609L and 
E609L(∆lacZ) strains were additionally supplemented with 12.5 µg/ml tetracycline, due 
to the Tn10 insertional mutation of the lpp gene.  
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Figure 4–1. Plasmid map of pQEkfiD(A) and pCEL (B). Abbreviations are as follows: 
AmpR: ampicillin resistance gene; ColE1: colE1 origin of replication; 
galE:lgtB: fusion gene of UDP-galactose-4-epimerase and β-1,4-
galactasyltransferase; kfiD: UDP-glucose dehydrogenase gene, lacIq: LacIq 
repressor; T5: phage T5  promoter; pBRR: Broad-Host-Range Vectors 
pBBR122 (MoBiTec). 
 
For the expression of UDP-glucose dehydrogenase, 10 ml of LB medium in a 50 
ml flask was inoculated with an overnight culture of SM101/pQEkfiD, SM105/pQEkfiD, 
E609L/pQEkfiD, and E609/pQEkfiD (2% inocula). Cells were grown at 28oC with 
shaking at 250 rpm. IPTG was added to a final concentration of 1 mM when OD600 
reached 0.5~0.7 and the cells were incubated for additional four hours at 28 oC. Cells 
were then collected for further analysis. For the study with different IPTG induction 
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concentrations, the cultivation was conducted under the same conditions as described 
above, except that different IPTG concentrations were added.  
For the expression of GalE-LgtB fusion protein, 100 ml of LB medium in a 500 
ml flask was inoculated with an overnight culture of E609L(∆lacZ)/pCEL and 
E609(∆lacZ)/pCEL and incubated at 30oC until OD600 reached 0.2~0.3, upon which IPTG 
was added to a final concentration of 1 mM. After induction, the cultivation was 
continued for another four hours at a lower temperature (25 oC).   
4.2.7 UDP-glucose dehydrogenase activity assay 
4.2.7.1 Whole cell activity assay 
Cultivation and induction conditions were as described in section 4.2.6. 0.5 ml of 
induced culture was collected in a 1.5 ml Eppendorf tube. Cells were harvested by 
centrifugation at 4,000 × g for 10 minutes at 4oC and washed once with 100 mM Tris-
HCl buffer (pH 9.0). Cell pellets were collected by centrifugation and resuspended into 
0.5 ml of same Tris-HCl buffer. The reaction was started by the addition of substrates, 
UDP-Glc and NAD+, to desired final concentrations. Samples were taken during the first 
30 minutes of the reaction at 37oC to measure the initial rate. The reaction was terminated 
by centrifugation at 13,000g for 5 minutes and the supernatant was subjected to an HPLC 
analysis (Hewlett-Packard 1100 Series). All activities were normalized by A600 to correct 
for small differences in cell density between preparations.  
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4.2.7.2 Cell extract activity assay 
The cell extract was prepared by removing cell envelopes using Bugbuster 
(Novagen, San Diego, CA) and lysozyme. Cell pellets were suspended in Bugbuster with 
20 µg/ml lysozyme, upon which they were incubated at 10oC and 250 rpm for 60 
minutes, followed by centrifugation at 13000 × g for 15 minutes at 4 oC. The supernatant 
was then analyzed for enzyme activity. The UDP-glucose dehydrogenase activity of cell 
extract was assayed spectrophotometrically by following the reduction of NAD+ at 340 
nm, using a UV/VIS spectrophotometer (Lambda 40 Spectrometer, Perkin Elmer). The 
reaction mixture contained 1 mM UDP-Glc, 2 mM NAD+, 2 mM dithiothreitol, 50 µl of 
cell extract, and 100 mM Tris-HCl buffer (pH 9.0) for a total volume of 1 ml. The 
reaction was initiated by the addition of the cell extract. The initial velocity of the NAD+ 
reduction (ε340 = 6,220 M–1cm–1) was measured during the first minute. The whole-cell 
activity assay and cell extract assay were compared and found to be consistent with each 
other.  
4.2.8 Freeze-thaw treatment 
 The effect of freeze-thaw on the whole-cell catalyzed-reaction rate was also 
studied. Cell pellets were frozen at -80oC for 30 minutes and thawed at room temperature. 
The reaction was then carried out under the conditions as described above. 
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4.2.9 Cell extract activity assay for GalE-LgtB fusion enzyme 
The GalE-LgtB fusion protein activity assay was conducted at 37oC in 100 mM 
pH 7.5 Tris-HCl buffer (0.5 ml final volume), which contained 5 mM UDP-Glc, 10 mM 
GlcNAc, 10 mM MnCl2, 1% bovine serum albumin and 0.44 ml cell extract. Cell extract 
was prepared as described in section 4.2.7.2 for UDP-glucose dehydrogenase. The 
reaction was terminated after 15 minutes by boiling the reaction mixture for 5 minutes. 
The precipitates were then removed by centrifugation at 13,000g for 5 minutes. The 
product of the reaction, LacNAc, in the supernatant, was analyzed by a Dionex BioLC 
system. One unit of GalE-LgtB fusion protein activity is defined as the amount of enzyme 
required to produce 1 µmol of LacNAc per minute. All activities were normalized by 
A600 to correct for small differences in cell density between preparations.  
4.2.10 Time course of LacNAc production 
Cells from 50 ml of culture were harvested by centrifugation at 4,000 × g for 10 
minutes at 4oC and washed once with 100 mM Tris-HCl buffer (pH 7.5) with 10 mM 
MnCl2. Cell pellets were collected by centrifugation and resuspended into 0.5 ml of the 
same buffer. The reaction was started by the addition of 10 mM UDP-Glc and 40 mM 
GlcNAc. The reaction mixture was shaken at 250 rpm and 37 oC, and samples were taken 
at regular intervals to monitor the progress of the reaction. Samples were centrifuged at 
13,000 × g for 5 minutes and the supernatant was analyzed by a Dionex BioLC system.  
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4.2.11 SDS-PAGE analysis 
The expression levels of UDP-glucose dehydrogenase and GalE-LgtB Fusion 
Protein were evaluated by SDS-PAGE analysis. Cell pellets were suspended in 100 µl 1 × 
SDS-PAGE sample buffer containing 2.5% 2-mercaptoethanol. The samples were boiled 
for 5 minutes and centrifuged briefly. 10 µl of samples and the marker were then loaded 
into a Ready 10 % Tris-HCl gel. The gel was stained using Coomassie Brilliant Blue R-
250 stain solution. 
4.2.12 Analytical Methods 
4.2.12.1 UDP-glucuronic acid assay 
The samples were analyzed using a Hewlett-Packard 1100 Series HPLC system 
(Palo Alto, CA) equipped with a quaternary pump and diode-array detector. A YMC 
reversed-phase J’Sphere ODS column, 150 m × 4.6 mm I.D., 4 µm particle size (Waters, 
Milford, MA) was used.  The ion-pairing method used was described previously54. 
4.2.12.2 LacNAc assay 
A Dionex BioLC HPLC system (Sunnyvale, CA) equipped with a GS50 gradient 
pump, ED50 electrochemical detector, and Dionex CarboPac PA10 column (4 × 250 mm) 
was used. Two solvents were used as eluents: 200 mM NaOH and H2O. The HPLC 
method consists of 3 steps: elution, regeneration, and equilibration. It was performed as 
follows: elution: 18% 200 mM NaOH and 82% H2O for 23 minutes; regeneration: 50% 
200 mM NaOH and 50% H2O for 15 minutes; equilibration: 18% 200 mM NaOH and 
82% H2O for 14 minutes.  
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4.3 Results 
4.3.1 Mutation effects on UDP-glucose dehydrogenase activity 
UDP-glucose is a relatively large molecule (molecular weight 610), close to the 
maximum size allowable through porins. In addition, since it is hydrophilic, there could 
be considerable mass transfer resistance in the highly hydrophobic inner leaflet of the 
outer membrane, which is made of phospholipids. Mutations at the outer membrane 
structures could lead to increased permeability. Two types of outer membrane mutants 
were used in this study. SM101 carries a mutation in the first enzyme of the Lipid A 
synthesis pathway, resulting in a reduced synthesis of LPS. E609L carries an insertional 
mutation in a structural protein, Braun’s lipoprotein, which provides a covalent link 
between the outer membrane and the peptidoglycans. The permeability of the membranes 
was evaluated by measuring the reaction rate catalyzed by an overexpressed enzyme, 
UDP-glucose dehydrogenase (Figure 4–2A). The respective parental strains were used as 
controls. Figure 4–3 shows a comparison of whole-cell activities between the mutants and 
the respective controls. Whole-cells carrying either type of mutation exhibited a much 
higher activity than their respective parental strains, increasing reaction rate by a factor of 
2.0–to–14, depending on the substrate concentrations used. Under all conditions, there 
were no significant differences in the expression levels of the enzyme between the mutant 
and the control. A typical SDS-PAGE gel is shown in Figure 4–4. This was further 
supported by the activity measurement in the cell extracts (prepared by removing cell 
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membranes) (Table 4–2).  Therefore, the differences observed in the reaction rate can be 
attributed to the altered rate of substrate uptake due to the mutations. 
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Figure 4–2. Reactions catalyzed by (A) UDP-glucose dehydrogenase and (B) GalE-
LgtB fusion protein.  
 
When whole-cell activities are compared to their cell extract activities, striking 
differences are evident (Table 4–2). At a relatively low substrate concentration (5 mM), 
the whole-cell activities for the parental strains only represent a small fraction of total 
activity inside the cells, about 4% for both E609 and for SM105, suggesting that severe 
permeability limitations imposed by the cell membranes. The mutations at the outer 
membrane structure dramatically increased the whole-cell activity, 9–fold for SM101 and 
14–fold for E609L, bringing it to about 34% of the cell extract level for SM101 and 60% 
for E609L. At a higher substrate concentration (20 mM), the LPS mutant recovered about 
73% of the activity, compared to about 19% with the parental strain. The lipoprotein 
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mutant recovered nearly 100% of the cell extract activity whereas only about 10 % 
activity was exhibited by the control strain. The results indicate that mutations at the 
outer membrane structures were effective in reducing the substrate permeability barrier in 
whole-cell catalysts. The lipoprotein mutation seemed to be particularly effective, 
capable of eliminating the permeability barrier under certain conditions.  
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Figure 4–3. The effect of substrate concentrations on the initial rate of whole-cell E. 
coli SM101/pQEkfiD (S), SM105/pQEkfiD (U), E609L/pQEkfiD () 
and E609/pQEkfiD (). 2 mM NAD+ was used in all reactions. Error bars 
represent standard deviations from the mean. All data are measured in at 
least three separate experiments. 
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Figure 4–4. SDS-PAGE analysis of the UDP-glucose dehydrogenase  expression in E. 
coli strains: SM101/pQEkfiD, SM105/pQEkfiD, E609L/pQEkfiD and 
E609/pQEkfiD. The cellular fractions were loaded on the gel as follows: 
marker (lane 1), 4 hr induced SM101/pQEkfiD (lane 2), 4 hr induced 
SM105/pQEkfiD (lane 3), 4 hr induced E609L/pQEkfiD (lane 4), 4 hr 
induced E609/pQEkfiD (lane 5). 
 
Table 4–2. A comparison of UDP-glucose dehydrogenase activity in whole-cell and 
cell extract of SM101/pQEkfiD, SM105/pQEkfiD, E609L/pQEkfiD and 
E609/pQEkfiD  
Activitya (mUnits/1 ml 1.0OD600 cell)   
SM101           SM105              E609L               E609 
Cell extract 43.0 ± 2.2 39.9 ± 0.4 49.5 ± 1.6 51.7 ± 5.7 
                                                                     At 5 mM Substrate Concentration  
Whole cell 14.7 ± 1.7 1.6 ± 0.1 29.5 ± 2.6 2.1 ± 0.2 
Whole cell/Cell extract (%) 34.2 4.0 59.6 4.1 
                                                                     At 20 mM Substrate Concentration 
Whole cell 31.4 ± 0.9 7.4 ± 0.7 48.8 ± 6.5 4.9 ± 1.1 
Whole cell/Cell extract (%) 73.0 18.5 98.6 9.5 
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aAll activities are measured in at least three separate experiments and expressed as means 
± 1 standard deviation. 
 
4.3.2 Enzyme expression levels on whole cell activities 
It is nowadays a common practice to use whole cells, overexpressing one or more 
enzymes, as catalysts. Often in these systems, the inducer concentration is used to 
modulate their activities. Higher activities usually correlate with higher expression levels. 
Although this is true in most cases with activities measured in cell extracts, in whole-cell 
system, if substrate permeability is a problem, the relation between the inducer 
concentration, the expression level, and the enzyme activity can be more complicated. 
Table 4–3 illustrates how the enzyme activity responds to the inducer concentrations. For 
E609, in the cell extract, the activity increased from about 2 mU to about 50 mU, a 25–
fold difference, when IPTG concentrations jumped from 0.01 mM to 1 mM. However, 
the whole-cell activity did not respond to the increase of IPTG nearly as dramatically, 
increasing the activity only 7 times for the same inducer concentration change. Clearly, 
the substrate permeability limitation diminished the cell’s gain from increased inducer 
concentrations. The mutant strain, E609L, which allowed the substrate greater 
permeability, was more sensitive to IPTG concentration change. The enzyme activity 
jumped about 11 times (Table 4–3).  This result indicates that substrate permeability is an 
important (yet often overlooked) factor that needs to be taken into account in the 
construction of recombinant whole-cell catalysts.  
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Table 4–3. UDP-glucose dehydrogenase activity of whole-cell and cell extract of 
E609L/pQEkfiD and E609/pQEkfiD at different IPTG concentrations. 
  Whole Cell Activity (mUnits)/1 ml 1.0 OD600 Cella
Conc. of IPTG  (mM) 0.01 0.1 0.5 1 
E609L 2.6 ± 0.4 20.5  ± 3.5 27.8 ± 1.7 29.5 ± 2.6 
E609 0.3 ± 0 1.8 ± 0.3 2.3 ± 0.1 2.1 ± 0.2 
  Cell Extract Activity (mUnits)/1 ml 1.0 OD600 Cell 
Conc. of IPTG  (mM) 0.01 0.1 0.5 1 
E609L 1.6 ± 0.3 32.6 ± 0.3 44.2 ± 1.6 49.5 ± 1.6 
E609 1.9 ± 0.1 33.2 ± 5.0 46.5 ± 1.4 51.7 ± 5.7 
 
aThe whole cell activity was measured with 5 mM UDP-Glc and 5 mM NAD+ as 
described in Materials and Methods. All activities are measured in at least three separate 
experiments and expressed as means ± 1 standard deviation. 
Interestingly, as the mutant E609L is more responsive to IPTG concentration than 
E609, the activity ratio of E609L to E609 increased with the increase of the inducer 
concentration (Figure 4–5), with more pronounced effects observed at lower IPTG 
concentrations (0.01–0.1 mM). The beneficial effects of outer membrane mutation, 
therefore, depend on the expression levels. 
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Figure 4–5. The effect of different IPTG concentrations on the whole-cell activity ratio 
of E609L/pQEkfiD to E609/pQEkfiD. 5 mM UDP-Glc and 5 mM NAD+ 
were used in all reactions. Error bars represent standard deviations from the 
mean. All activities are measured in at least three separate experiments. 
 
4.3.3 Mutation versus freeze-thaw  
The effectiveness of outer membrane mutation in reducing substrate permeability 
limitations was compared to a common permeabilization procedure, freeze-thaw (FT), 
known to be effective in permeabilizing cell membranes for UDP-glucose55. Figure 4–6 
shows that mutation of the LPS synthesis pathway is much more effective, increasing the 
whole-cell activity by about 9 times versus 2 times with FT. Similarly, the lipoprotein 
mutation led to an increase of nearly 14–fold, compared to about 5–fold with FT. Besides 
being more effective, the genetic engineering approach eliminates the need for additional 
processing steps, time, and equipment. Therefore, modification of the outer membrane is 
far superior to FT treatment.  
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Figure 4–6. A comparison of membrane mutation and freeze-thaw method. 5 mM UDP-
Glc and 5 mM NAD+ were used in all reactions. Error bars represent 
standard deviations from the mean. All data are measured in at least three 
separate experiments. 
 
4.3.4 LacNAc synthesis from UDP-glucose 
As an example of the application of outer membrane mutants in synthesis, we 
studied the LacNAc synthesis from UDP-glucose. LacNAc is one of the most common 
core structures in glycans, some of which are significantly elevated in various types of 
cancer patients56. Its synthesis from UDP-glucose is of particular interest as UDP-glucose 
is 100 times less expensive than UDP-galactose, . To achieve high synthesis with whole-
cell catalysts, host modification is necessary to remove the β-galactosidase activity, 
which hydrolyzes the product. This was done by knocking out the β-galactosidase 
encoding gene (lacZ) from the chromosome of E609 and E609L. A PCR-based gene-
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knockout method was used. The resulting knockouts were verified by gene sequencing 
and activity assay (data not shown). The two required enzymes, UDP-galactose 4’-
epimerase (galE, catalyzing the reversible conversion between UDP-glucose to UDP-
galactose) and a β-1, 4-galactosyltransferase (lgtB, catalyzing the addition of a galactose 
from UDP-galactose in beta 1 to 4 linkage to N-acetylglucosamine to yield LacNAc), 
were introduced as a fusion (Figure 4–1B; Detailed construction of the plasmid is given 
in the section 4.2.5). The reaction yielding LacNAc is shown in Figure 4–2B.  
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Figure 4–7. The time course of LacNAc production by whole-cell E609L(∆lacZ)/pCEL 
() and E609(∆lacZ)/pCEL (). 10 mM UDP-Glc and 40 mM GlcNAc 
were used in the reaction. Error bars represent standard deviations from the 
mean. All data are measured in at least three separate experiments. 
 
 Figure 4–7 is a comparison between E609L(∆lacZ)/pCEL and E609(∆lacZ)/pCEL 
in the synthesis of LacNAc. The initial rate of synthesis was about 2.5 times higher for 
the lipoprotein mutant. In addition, there were substantial differences in product yields. 
Under the same conditions, the mutant gave a product yield of 100% (based on the input 
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of UDP-glucose), whereas the parental strain gave only 50% yield. This difference may 
be due to the product inhibition by UDP, which was found to have accumulated in the 
parental strain (data not shown). The accelerated reaction rate can be attributed to the 
increased permeability resulting from the lipoprotein mutation, as there was no 
significance difference in the expression levels of the two strains (Figure 4–8).  
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Figure 4–8. SDS-PAGE analysis of the GalE-LgtB fusion protein expression in E. coli 
E609L(∆lacZ)/pCEL and E609(∆lacZ)/pCEL. The cellular fractions were 
loaded on the gel as follows: 4 hr induced E609L(∆lacZ)/pCEL (lane 1), 4 
hr induced E609(∆lacZ)/pCEL (lane 2), marker (lane 3). 
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4.4 Discussion 
This study demonstrates that UDP-glucose, as a large hydrophilic molecule, has 
severe limitations of permeability in the outer membrane. At 5 mM substrate 
concentration, only a small percentage (4%) of the possible enzyme activities was 
exhibited in a whole-cell system. Modifications of the outer membrane structure are 
effective in reducing these limitations as shown by the dramatically increased rate of 
reactions (up to 14–fold) in the mutants. In particular, nearly 100 % of the available 
enzyme activity (in cell extracts) was recovered in cells with the lipoprotein mutation at 
20 mM substrate concentration. The gains of the mutation in reaction rate are the result of 
increased intracellular substrate concentrations, which can be illustrated with the 
following analysis. We assume that the simple Michaelis-Menten kinetics applies to the 
UDP-glucose dehydrogenase, and Km value for UDP-glucose is 0.015 mM57, and Vmax 
measured in this study are 41.5 mU for SM105 and SM101, and 50 mU for E609 and 
E609L. The intracellular concentrations of UDP-glucose in the whole cells were 
estimated using this model. They are tabulated in Table 4–4. The intracellular substrate 
concentrations for wild-type cells are 3–4 orders of magnitude lower than the 
extracellular concentration. This is consistent with the general observation that the whole-
cell catalyzed rate is usually orders of magnitude lower than of the isolated enzyme 
counterpart. Mutations at the outer membrane increase the intracellular concentration by 
10–to–380–fold (Table 4-4). The mutations coupled with increased extracellular substrate 
concentration raised the level of intracellular substrate concentration 3–to–40–fold above 
the Km value; consequently, whole cells exhibited almost the maximum activity.  It is 
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important to note that a substrate concentration of 5 mM is 330–fold higher than the Km 
value. Supplying a substrate at this high concentration allows the reaction to proceed at 
approximately two orders of magnitude (instead of four orders of magnitude as predicted 
from the intracellular concentration) lower than the isolated enzyme counterpart. If the 
substrate concentrations was not supplied that high, the whole cell activity could well fall 
below the detection level. This could lead to erroneous conclusions in biocatalyst 
screening and development. This model analysis depicts a drastically different 
environment that an enzyme experiences intracellularly and illustrates, once again, the 
need and the importance to evaluate substrate permeability in whole-cell biocatalysis 
research.  
 
Table 4–4. Intracellular UDP-glucose concentration estimated using the Michaelis-
Menten Model. 
  Modeled Intracellular Concentration (µM) 
 SM101 SM105 E609L E609 
 At 5 mM Extracellular Concentration 
Intracellular Concentration  8.23 0.60 21.59 0.66 
Ratio: Extracellular to Intracellular 608 8313 232 7603 
Ratio: Mutant to Parent 13.68  30.82  
Ratio: Concentration to Km 0.55 0.04 1.44 0.04 
 At 20 mM Extracellular Concentration 
Intracellular Concentration  46.63 3.26 610.00 1.63 
Ratio: Extracellular to Intracellular 429 6144 33 12272 
Ratio: Mutant to Parent 14.33  374.30  
Ratio: Concentration to Km 3.11 0.22 40.67 0.11 
 
The enzymes investigated, UDP-glucose dehydrogenase and the epimerase-
galactosyltransferase fusion, were both over-expressed in the cytoplasm. As the inner 
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membrane is highly hydrophobic, it is expected that the molecule also experiences 
limitations in the penetration of the inner membrane. This may be reflected by the fact 
that even with substantial outer membrane permeabilizing, only up to 60% of the activity 
was recovered at 5 mM substrate concentration. Only at a much higher substrate 
concentration (20 mM) was 100% activity recovery achieved. Our current system does 
not allow an assessment of the inner membrane permeability. As a matter of fact, our 
initial efforts in isolating the outer membrane permeability from inner membrane 
permeability (by expressing these enzymes in periplasmic space) resulted in either 
inactive enzymes or very low level expression, not conducive to the permeability study. 
Nevertheless, the significant rate acceleration achieved by mutations on the outer 
membrane structure suggests that the outer membrane permeability barrier for this 
molecule is significant and substantial reduction could be achieved through membrane 
engineering. If inner membrane permeability can be addressed, the maximum activity 
could be reached at an external substrate concentration lower than 20 mM.  
 This, along with our earlier work, , indicates that the beneficial effects of outer 
membrane mutation seem to be universal to all six molecules investigated. However, the 
gains in rate acceleration due to mutations varies from a mere 120%–to–1400%, and 
appears to be dependent, in a complicated manner, on the molecular structures of the 
substrate molecules (such as size and hydrophobicity), and the exact nature and locations 
of the mutation. This warrants further investigation. Finding a correlation of mutational 
effects to the molecular features of substrates will allow membrane structures to be 
tailored for specific process needs. The gains, as illustrated in this work, are also 
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dependent on the enzyme expression levels and substrate concentrations. Other 
conditions that influence enzyme reaction rates such as pH and temperature could also 
affect the rate accelerations, which await further studies.  
The severe limitations of substrate permeability on whole-cell reaction rates, as 
revealed in this paper, as well as our earlier work and that of others–7, , , , 58, 59, clearly 
demonstrates a need for an assessment of membrane permeability in biocatalysis research 
and development. The dramatic improvement in the reaction rate with outer membrane 
mutants testifies to the effectiveness of using a molecular engineering approach to 
address this permeability problem. Although so far our work has been done exclusively 
with substrates, permeability problems with products produced and accumulated 
intracellularly could conceivably be addressed using the same membrane engineering 
strategies as illustrated in this work.  
 CHAPTER 5 
Significance and Application of lpp Lipoprotein Mutation in Whole-cell Biocatalysis 
 
Our previous studies with a Braun’s lipoprotein mutant E609L demonstrated that  
lipoprotein mutation in outer membrane could be an effective method to increase 
permeability of a variety of substrates38, , 60. The results showed that reactions with all six 
substrates were dramatically accelerated by this lipoprotein mutation (up to 14–fold 
increase in reaction rate). In order to establish this as a generally applicable methodology 
for accelerating whole-cell biocatalysis, we decided to investigate an alternative genetic 
modification to obtain the same phenotype. The lpp gene deletion was successfully 
introduced into E. coli strains from different genetic background and the resulted strains 
were characterized. It showed that the deletion had the same effect on substrate 
permeability as the original transposon mutation. Also, the lpp deletion was found to have 
no significant effect on cell growth, carbon metabolism, and lipid compositions. An 
example was illustrated with L-carnitine production by introducing lpp deletion into the 
E. coli O44K74 strain to achieve a higher product yield. This method might be generally 
applicable to biocatalysis processes as the permeability change effected by the mutation 
is of global nature. These results demonstrate that a useful phenotype can now be 
transferred to any E. coli strain with a straightforward genetic manipulation to effectively 
enhance the rate of a whole-cell biocatalysis reaction. 
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5.1 Introduction 
The increasing environmental and economic pressure in past decade has 
stimulated tremendous progress in the use of enzymes and microorganisms for the 
production of fine chemicals, pharmaceuticals as well as food ingredient. Biocatalysis has 
developed from a niche technology to a widely used manufacturing method. In many 
cases, especially in large scale applications, whole-cell biocatalysts are preferred to free 
enzymes. First, the isolation and purification of enzymes not only significantly increase 
the cost but also might render full or partial loss of activity, while the use of whole cells 
don’t have these problems. Also, the whole-cell system allows the cascades of enzyme 
reactions involve multiple enzymes, cofactors and substrates, . However a major obstacle 
in the application of whole-cell biocatalysts is the limited reaction rate and yield due to 
the formidable permeability barrier imposed by cell envelope.  
Our previous studies with a Braun’s lipoprotein mutant E609L demonstrated that 
genetic modification in outer membrane could be an effective method to increase the 
reaction rate by reducing the substrate permeability barrier. It showed that reactions with 
all six substrates were dramatically accelerated by this lipoprotein mutation (up to 14–
fold increase in reaction rate). The lipoprotein mutation was proven to be effective 
towards substrates with various size and hydrophobicity. Additionally, the lipoprotein 
mutation has essentially no effect on its growth and high level expression of recombinant 
protein38, , . The extraordinary performance of the lipoprotein mutant E609L suggests that 
it would be of great interest to apply this as a generally methodology for accelerating 
whole-cell biocatalysis. The sequence result of E609L suggests that the lpp gene is 
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completely inactivated by an transposonal insertion containing multiple stop codon. 
Consequently, the same phenotype could be obtained by introduction of lpp gene deletion 
into strains with different genetic background. The resulted lpp deletion strain showed the 
same effect on substrate permeability as the original transposon mutant E609L. Further, 
the lpp deletion had no significant effect on cell growth, carbon metabolism and lipid 
compositions. The result indicates that the lpp deletion could be established as a general 
method for accelerating whole-cell biocatalysis.  
An application was illustrated with L-carnitine production. L-carnitine [R-(-)-3-
hydroxy-4-trimethylaminobutyrate] is essential for the transport of long-chain fatty acids 
through the inner mitochondrial membrane in eukaryotes. With the identification of its 
clinical and biotechnological importance, the demand for L-carnitine has increased 
worldwide. Several chemical and biological processes have been developed for its 
synthesis 61 . Compared to the racemic carnitine product from chemical process, 
biotransformation converts achiral precursors, such as crotonobetaine to optical purity L-
carnitine, which is safe to be administered to the patients. E. coli O44K74 has a 
significantly higher carnitine dehydratase than other E. coli strains and has been 
employed in the production of L-carnitine, , , . However, the biotransformation process 
using whole cells resulted in a maximum of only 30–43% conversion ratio due to 
unfavorable reaction equilibrium, limitations in transport system and side product 
formation 62 , 63  (as depicted in Figure 5–1). Permeabilization by either detergents or 
polyethylenimine to achieve higher yield of L-carnitine was reported64. But the chemical 
treatment is far from being desirable, especially for large scale applications, since they 
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are usually non-specific and incur unintended damage to cell (even lysis), and also 
complicate the downstream process. In this study, the lipoprotein mutation was 
successfully introduced into L-carnitine production strain E. coli O44K74 by deleting the 
lipoprotein encoding gene lpp using a straightforward and efficient PCR-based method. 
The results showed that higher product yield of L-carnitine synthesis was achieved by lpp 
deletion strain due to its increased outer membrane permeability. The faster export of L-
carnitine by the mutant cells allowed the reversible reaction catalyzed by carnitine 
dehydratase to continue in a favorable direction and the product to escape from the 
degradation by side reactions (Figure 5–1). These results demonstrate that a useful 
phenotype can now be transferred into any E. coli strain to effectively enhance the rate of 
a whole-cell biocatalysis reaction.  
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Figure 5–1. Biotransformation of crotonobetaine to L-carnitine catalyzed by carnitine 
dehydratase and the related side reactions (in squares) in E. coli whole 
cells.  
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5.2 Experimental 
5.2.1 Chemicals and reagents 
 All chemicals were reagent grade and used as received. Methyl esters of 
myristic acid (C14:0), palmitic acid (C16:0), palmitoleic acid (C16:1) and cis-vaccenic 
acid (C18:1), L-carnitine, Acetyl-CoA, dithiobisnitrobenzoic acid (DTNB), carnitine 
acetyltransferase (CAT), and N-phenyl-1-naphthylamine (NPN) were purchased from 
Sigma Chemical Co. (St. Louis, MO). Crotonobetaine was graciously provided by Dr. 
Manuel Canovas, . All primers used in this study were from Invitrogen (Carlsbad, CA) 
and listed in Table 5–1.   
 
Table 5–1. List of oligonucleotide primers used in this study. 
Primer  
name 
Primer sequencea
lpp-f 5’ -CTTTGTGTAATACTTGTAACGCTACATGGAGATTAACTCAATCTAGAGGGGTGTAGGCTGGAGCTGCTTC- 3’ 
lpp-r 5’ -CGTGACGCAGTAGCGGTAAACGGCAGACAAAAAAAATGGCGCACAATGTGATTCCGGGGATCCGTCGACC- 3’ 
lpp-up 5’ -CACTACTAACACCGCATCTG- 3’ 
lpp-dn 5’ -GCCATACACACTGCCAGCAG- 3’ 
a Homologous regions are underlined 
 
5.2.2 E. coli Strains 
E. coli strains used in this study are shown in Table 5–2. E609L carries a Tn10 
insertion in lpp coding for Braun’s lipoprotein. E609Y is the lpp knockout strain 
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constructed in this study. E609 is the isogenic parent of E609L and E609Y. E. coli 
O44K74, a gift from Dr. Marie-Andree Mandrand, has a significant higher carnitine 
dehydratase activity and was used for L-carnitine synthesis65. E. coli O44K74Y is the lpp 
knockout strain constructed using E. coli O44K74 as the parent strain. 
 
Table 5–2. E. coli strains used in this study.   
 
Description Source 
E609L lpp::Tn10; periplasmic leaky; Tcr K. W. Miller, 
(labcin@uwyo.edu) 
E609Y lpp deletion strain this study 
E609 HfrC pps, isogenic parent of  
E609L and E609Y 
K. W. Miller, 
O44K74Y lpp deletion strain this study 
O44K74 Isolated from the intestine of a rat 
for its higher carnitine dehydratase 
activity. Isogenic parent of  
O44K74Y 
M-A Mandrand 
(marie-andree.mandrand@insa-
lyon.fr) 
 
5.2.3 Construction of lpp knockout strains 
The lpp knockout strain was constructed using the gene inactivation method 
developed by Wanner and coworkers. Briefly, the FRT–flanked kanamycin resistance 
gene was PCR amplified using primers (lpp-f and lpp-r, as shown in Table 5–1) with 50–
nucleotide extensions that are homologous to the adjacent regions of the genomic lpp 
gene. Homologous recombination was mediated by the plasmid–borne phage λ Red 
recombinase. The kanamycin gene was then excised by helper plasmid encoding the FLP 
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recombinase. Finally, both plasmids were easily cured by growth at above 37°C as they 
contain temperature-sensitive replicons.  
5.2.4 Characterization of lipoprotein mutant E609Y 
5.2.4.1 Growth curve 
LB and M9 minimal medium were used in cultivations. M9 minimal medium 
contained per liter: 6.8 g Na2HPO4; 3.0 g KH2PO4; 0.5 g NaCl; 1.0 g NH4Cl; 3.6 g 
glucose; 0.50 g MgSO4·7H2O, 0.015 g CaCl2·2H2O. Other supplements included 20 
amino acids at a final concentration of 40 µg/ml each. The medium for E609L was 
additionally supplemented with 12.5 µg/ml tetracycline.  For cell growth study, 100 ml of 
medium in a 500 ml flask was inoculated with an overnight culture of E609Y, E609L and 
E609 (2% inocula). The flasks were shaken in a rotary shaker at 250 rpm at 37 oC. 
Samples were taken from each culture at regular intervals to monitor the growth pattern 
by measuring optical density at 600 nm with a UV/VIS spectrophotometer (Lambda 40 
Spectrometer, Perkin Elmer).  
5.2.4.2 Lipid extraction, fractionation and analysis 
Phospholipids were extracted by the method of Bligh and Dyer, as modified by 
Ames66. Briefly, stationary phase cells (500 mg wet weight) were washed with 10 mM, 
pH7.4 sodium phosphate buffer and resuspended in 1.6ml of same buffer, after which 4 
ml of methanol and 2 ml of chloroform were added with thorough mixing (water, 
methanol and chloroform are in the proportion of 0.8:2:1, v/v). The suspension was 
incubated in room temp for 2 h with periodic vortexing. The extract mixture was diluted 
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with 2 ml of chloroform followed by 2 ml of same buffer, whereupon the phase was 
thoroughly mixed. After brief centrifugation, the lower chloroform phase (containing 
lipids) was removed and subjected to further esterification. The lipid extracts were 
esterified with 5% H2SO4 in methanol at 70oC for 2 hours. The fatty acid methyl esters 
(FAMEs) were extracted with n-pentane. The pentane was removed with air stream, and 
the FAMEs were dissolved in 1 ml of n-heptane for further gas chromatography-mass 
spectrometry (GC/MS) analysis. 
The fatty acid profile was determined with Hewlett-Packard 6890 GC coupled to 
a HP5973 MSD (Palo Alto, CA). The temperature for the injector and the MSD was 280 
oC. The GC inlet was operated in the splitless mode at 230 oC. One microliter was 
injected from a 10-µl syringe by an HP7683 autosampler. An HP-5MS 
methylpolysiloxane phase column (30 m × 0.25 mm × 0.25 µm) was used, with helium as 
carrier gas at 1 ml/min. The GC oven heated the column with a program started at 60oC 
for 2 minutes, ramped at 10 oC/min to 150 oC, then ramped at 3 oC/min to 250 oC, finally 
ramped at 10 oC/min to 300 oC, held for 5 minutes. Authentic FAME samples and the MS 
spectrum were used to determine the retention times and identify individual fatty acids 
derived from the strains. Retention times of identified FAMEs are shown in Table 5–3.  
5.2.5 Application of lipoprotein mutant for L-carnitine production 
5.2.5.1 Cell preparation 
  E. coli strains O44K74 and O44K74Y  (Table 5–2) were aerobically grown in 
LB medium at 30oC with 250 rpm 15 hrs to obtain the seed culture. Cells were cultivated 
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in complete medium inoculated with 2 % (v/v) of overnight seed culture and incubated 
for 24 hrs under anaerobic conditions at 37oC in completely filled, air-tight flasks without 
stirring. The complete medium contained per liter: 20 g peptone, 12.6 g glycerol, 5 g 
NaCl, 2 g fumarate, supplemented with 50 mM crotonobetaine to induce the expression 
of the enzymes involved in carnitine metabolism. 
5.2.5.2 Biotransformation using resting cells 
 Cells were harvested after overnight growth by centrifugation at 4,000 g for 15 
minutes, washed twice with 35 mM potassium phosphate buffer (pH 7.5), and 
resuspended to around 10 OD600  (~20 g wet cell/liter) in 60 mM potassium phosphate 
buffer (pH 7.5) with 50 mM crotonobetaine. Biotransformation was carried out 
aerobically at 37oC and 250 rpm shaking. Samples were taken every hour to monitor the 
progress of the biotransformation.  
5.2.5.3 L-carnitine analysis 
 L-carnitine concentration was determined enzymatically with the carnitine 
acetyl transferase methods, based on a colorimetric reaction. Reaction mix included 0.3 
mM DTNB, 0.06 mM Acetyl-CoA, 2.5 mM EDTA, 0.25 U CAT, and 100 µl of 
appropriately diluted sample in 50 mM phosphate buffer (pH 7.5). Absorbance at 412 nm 
was monitored using a UV/VIS spectrophotometer (Lambda 40 Spectrometer, Perkin 
Elmer) after the reaction mixture was incubated at 30oC for 30 min. L-carnitine 
production yield was determined as the percentage of L-carnitine produced over the 
crotonobetaine supplied in biotransformation.  
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5.3 Results 
5.3.1 Sequence analysis of lpp in E609L 
Braun’s lipoprotein, the major outer membrane lipoprotein encoded by lpp, is 
present in some 700,000 copies per cell, which makes it the most abundant protein in 
numerical sense in E. coli. About one–third of the lipoprotein molecules are covalently 
linked to murein and help hold the two structures together. Therefore the rigidness of the 
outer membrane can be attributed to the interaction between the lipoprotein and the 
murein layer. Mutants defective in the structural gene for this protein are fully viable, 
indicating it is nonessential. However, it is possible the disruption of lipoprotein will 
affect the global membrane integrity and thus may effect some changes in substrate 
permeability. Our previous studies, ,  with the mutant, showed dramatically increased 
permeability with various substrates, ranging from hydrophilic (e.g. nitrocefin) to 
hydrophobic (e.g. tetrapeptide), small (e.g. toluene) to big molecules (e.g. UDP-glucose). 
The acceleration in reaction rate due to the mutation was as high as 14 times, suggesting 
the important effect of lipoprotein on membrane permeability. To have an insight into the 
molecular basis behind this phenotype, and also to provide knowledge for future rationale 
design of membrane mutants, the lpp region in E609L were sequenced and compared to 
E609 (Fig. 5–2A). Primers lpp-up and lpp-dn (Table 5–1) were used for DNA 
sequencing. As expected, a 59-bp insertion (in grey) at 17th bp of lpp was found in 
E609L. Moreover, the insertion contains two double-stop codon (in bold), indicating lpp 
is not expressed at all. Therefore, the absence of this major outer membrane lipoprotein is 
94 
responsible for the strikingly increased permeability. This is the first time that the genetic 
sequence information of this lipoprotein mutation was revealed. And most importantly, it 
indicates that the same phenotype as transposonal mutation could be obtained by a simple 
lpp deletion.  
 
 E609            ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACT-------------------- E609L           ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACTCTGATGAATCCCCTAATGAT 
                 ****************************************                     
 
E609            ---------------------------------------GGTACTGGGCGCGGTAATCCT 
E609L           TTTGATAAAAATCATTAGGGGATTCATCAGTACTAAACTGGTACTGGGCGCGGTAATCCT 
                                                                ********************* 
 
E609            GGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTGA 
E609L           GGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTGA 
                 ************************************************************ 
 
E609            CGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTTC 
E609L           CGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTTC 
                 ************************************************************ 
 
E609            CGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGGC 
E609L           CGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGGC 
                 ************************************************************ 
 
E609            TACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCAT 
E609L           TACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCAT 
                 ************************************************************  
Figure 5–2A. Comparison of nucleotide sequences of lpp from E609L and E609Y. Start 
and stop codon are in bold. The grey part represents the 59-bp insertion 
introduced by transposon. 
 
5.3.2 Construction of lpp knockout strains 
The significant effect of the lipoprotein mutation also suggests that it would be of 
interest to introduce lpp knockout into strains with different genetic backgrounds and 
establish this as a general method to accelerate reaction rate of whole-cell biocatalysis. 
The lipoprotein mutant E609L used in earlier studies, ,  was generated by phage 
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transduction mediated transposon insertion, a time-consuming and labor-intensive 
method in which tedious selection steps are involved. Here, a straightforward and highly 
efficient, one-step PCR-based gene inactivation method was investigated to introduce lpp 
deletion. The method leaves no antibiotic resistance gene marker, which is another 
advantage over transposon insertion. 
 
 E609 AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA O44K74 AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA 
E609Y AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA 
O44K74Y AAAAAAATATTCTCAACATAAAAAACTTTGTGTAATACTTGTAACGCTACATGGAGATTA 
************************************************************ 
 
E609 ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACTGGTACTGGGCGCGGTAATCC 
O44K74 ACTCAATCTAGAGGGTATTAATAATGAAAGCTACTAAACTGGTACTGGGCGCGGTAATCC 
E609Y ACTCAATCTAGAGGG--------GTG--------TAGGCTGGAGCTG------------- 
O44K74Y ACTCAATCTAGAGGG--------GTG--------TAGGCTGGAGCTG------------- 
***************           **          **  ****  ***              
 
E609 TGGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTG 
O44K74 TGGGTTCTACTCTGCTGGCAGGTTGCTCCAGCAACGCTAAAATCGATCAGCTGTCTTCTG 
E609Y ------------------------------------------------------------ 
O44K74Y ------------------------------------------------------------ 
                                                                             
 
E609 ACGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTT 
O44K74 ACGTTCAGACTCTGAACGCTAAAGTTGACCAGCTGAGCAACGACGTGAACGCAATGCGTT 
E609Y ---------CTTCGAA-----------------------------------------GTT 
O44K74Y ---------CTTCGAA-----------------------------------------GTT 
           **  ***                                                 *** 
 
E609 CCGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGG 
O44K74 CCGACGTTCAGGCTGCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACATGG 
E609Y CCTATACTT-------------------------------------TCTAGAGAATAGGA 
O44K74Y CCTATACTT-------------------------------------TCTAGAGAATAGGA 
** *   *                                              *** ** ** * *  
 
E609 CTACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCA 
O44K74 CTACTAAATACCGCAAGTAATAGTACCTGTGAAGTGAAAAATGGCGCACATTGTGCGCCA 
E609Y --ACTTCGAACTGCAGGTCGACGGATCCCCGGAAT-----------CACATTGTGCGCCA 
O44K74Y --ACTTCGAACTGCAGGTCGACGGATCCCCGGAAT-----------CACATTGTGCGCCA 
***     ** *** **    * * *   * * *               ************** 
 
E609 TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCACGCGTAACATATTCCCTTGCTCTGGT 
O44K74 TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCGCGCGTAACATATTCCCTTGCTCTGGT 
E609Y TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCACGCGTAACATATTCCCTTGCTCTGGT 
O44K74Y TTTTTTTTGTCTGCCGTTTACCGCTACTGCGTCGCGCGTAACATATTCCCTTGCTCTGGT 
********************************* **************************  
Figure 5–2B. Comparison of nucleotide sequences of lpp from E. coli E609, E609Y, 
O44K74 and O44K74Y. Start and stop codon are in bold. Grey part 
represents the 82-bp scar after the gene deletion. 
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As our first application of this lpp deletion (detailed in the Experimental section), 
lipoprotein mutant strains E609Y and O44K74Y were generated by deleting gene lpp 
from their chromosomal DNA of their respective parent strains, E609 and O44K74. The 
resulting lpp deletion strains were verified by PCR and sequencing. As shown in Fig. 5–
2B, the gene deletion leaves behind an 82–bp scar (in grey) in place of lpp. 
The effect of the lpp deletion on the membrane permeability was studied with 
UDP-glucose dehydrogenase catalyzed reaction utilizing UDP-glucose as substrate (as 
described in Chapter 4). The result showed that the lpp deletion had the same effect on 
the membrane permeability as transposon mutation in E609L, ~15–fold increase in the 
reaction rate was observed. 
5.3.3 Characterization of the lpp knockout strain E609Y  
5.3.3.1 Growth and metabolism 
As one of the essential attributes of whole-cell biocatalysts, growth ability of lpp 
deletion strain E609Y was studied and compared to its parental strain E609 and the 
transposon mutant, E609L. Two different media, LB and M9 minimal were used to 
evaluate the growth of the mutant cells in both rich and minimal environment. As shown 
in Figure 5–3A, three strains exhibited the similar growth rate in LB media with a 
doubling time of about 0.7 hour. At the 8th hour of the growth, the cell density of ~3.0 
OD600 was reached for three strains with the highest of ~3.2 OD600 observed for E609.  
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Figure 5–3. Comparison of growth curve of E609Y(), E609L() and E609(U). (A) 
LB medium; (B) M9 minimal medium. 
 
In M9 minimal medium (Fig. 5–3B), two lipoprotein mutants, E609Y and E609L, 
exhibited the exactly same growth profile as expected. E609 showed higher growth rate 
than that of the mutants throughout the growth. The doubling time is 0.95 hour and 0.8 
hour for the mutants and the parent strain, respectively. The final cell density in M9 is 
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~2.0 OD600, one third lower than that of LB medium. Similarly, E609 ended up with a 
cell density bit higher (~0.2 OD600) than that of the mutants. 
Also, the glucose consumption was monitored when cells were grown in minimal 
medium under aerobic and anaerobic conditions. To our surprise, the result showed that 
the glucose consumption rate of the mutant cells was exactly the same as the parent 
strain, even under anaerobic condition (data not shown). It suggests that the mutant cells 
are able to maintain the normal cell growth and metabolism without consuming more 
carbon source. This is especially attractive in large-scale applications since no additional 
cost on medium material is required. 
 Taken together, the lipoprotein mutant E609Y cells fare quite well in both LB and 
minimal medium. The lipoprotein mutation doesn’t significantly affect the cell growth 
and carbon metabolism. The slower growth rate of mutant is likely to be caused by the 
involvement of more complicated metabolism in minimal medium to compensate the 
membrane defect. Limitation of energy source and accumulation of waster products could 
be responsible for this observation.  
5.3.3.2 Fatty acid profile  
The lipids of E. coli, exclusive of lipid A of lipopolysaccharide, are entirely 
phospholipids, comprising 9.1% of total dry cell weight. The most common fatty acids 
found in phospholipids are palmitic acid (16:0); palmitoleic acid (16:1); cis-vaccenic acid 
(18:1). Modulation of fatty acid composition to ensure appropriate membrane fluidity and 
rigidity is an important bacterial strategy for growth in different environment. It 
reported67, , ,  68 69 70 that most bacteria can maintain membrane fluidity and integrity by 
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adaptation accomplished by changing membrane fatty acid chain length, branching 
pattern, and unsaturation degree. Proper membrane rigidity can be achieved by increasing 
longer-chain fatty acids and decreasing shorter-chain fatty acids. Cyclopropane fatty acid 
was also found to be important to the rigidity of the cell membrane and it showed that 
decrease of cis-9,10-methylene hexadecanoic acid (C17:cyc) resulted in increased 
membrane rigidity71. These studies suggest that there is a control mechanism in E. coli 
that regulates the fatty acid compositions to keep the variations in the physical properties 
of the membrane phospholipids to a minimum. 
In this study, we speculate that lipoprotein mutant E609Y cells is probably 
subjected to the same control mechanism, that is, altering fatty acid composition to 
compensate the compromised membrane integrity and rigidity. We therefore carried out a 
comparison study to evaluate the effect of lipoprotein mutation on membrane fatty acid 
profiles in E609 and E609Y cells. The GC-MS analysis result showed that eight major 
fatty acids were found in membrane lipid extracts (Figure 5–4). In agreement with earlier 
studies, C16:1, C16:0 and C18:1, are 3 of the most abundant membrane fatty acids in 
both strains, constituting over 90% of total fatty acids. Other lipids including C14:0, 
C15:0, C17:cyc, C17:0, C18:0 make up the rest. The changes in fatty acid compositions 
of two strains were not dramatic, small but reproducible changes were noted. Compared 
to E609, the levels of short-chain fatty acids (C14:0, C15:0, C16:1 and C16:0) and 
cyclopropane fatty acid (C17:cyc) in E609Y were decreased for about 5% (Table 5–3). 
This was accompanied by an increase of long-chain fatty acids (C17:0, C18:1 and C18:0) 
(Table 5–3). Noticeably, one of the most abundant fatty acid C18:1 increased 4% in 
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E609Y. Therefore, the E609Y cells could manage to balance the increased membrane 
fluidity caused by lipoprotein deficiency by modulating proportions of membrane fatty 
acids without significant change in their compositions. 
 
Table 5–3. Comparison of fatty acid compositions of E609Y, E609L and E609. 
Fatty acid (%)a
Major 
Fatty acids 
Molecular 
weight 
Retention 
Time (min) E609Y E609 
Difference 
between E609Y 
and E609 
C14:0 242 18.3 3.7±0.8 5.0±0.2 -1.3 
C15:0 256 20.8 2.7±0.8 2.8±1.0 -0.1 
C16:1 268 23.2 23.7±1.4 23.9±2.8 -0.2 
C16:0 270 23.8 38.3±1.8 40.3±1.1 -2.0 
C17:cyc 282 26.0 6.7±1.8 7.6±2.1 -0.9 
C17:0 284 26.4 2.0±0.8 1.3±0.3 0.7 
C18:1 296 28.8 20.6±2.9 16.9±0.2 3.7 
C18:0 298 29.2 2.4±0.4 2.1±0.4 0.3 
a The values represent weight percentages of total fatty acids and are expressed as means 
± 1 standard deviation for three independent experiments. 
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Figure 5–4. Gas chromatography of membrane fatty acids of E609Y(A) and E609(B). 1. 
myristic acid (C14:0); 2. pentadecanoic acid (C15:0); 3. palmitoleic acid 
(C16:1); 4. palmitic acid (C16:0); 5. cis-9,10-methylene hexadecanoic acid 
(C17:cyc); 6. heptadecanoic acid (C17:0); 7. cis-vaccenic acid (C18:1); 8. 
octadecanoic acid (C18:0). 
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5.3.4 Biotransformation using E. coli O44K74Y resting cells 
 It has been reported that the biotransformation processes for L-carnitine 
production (Figure 5–1) using E. coli O44K74 cells can only result in a maximum of 30–
43% yield due to unfavorable reaction equilibrium, transport limitations and side product 
formation,64. Both substrate (crotonobetaine) and product (L-carnitine) are hydrophilic 
with MW of around 200. Chemical permeabilizers such as organic solvents (ethanol, 
acetone and toluene), detergents (Tween 20 and Triton X-100) and polyethylenimine 
were used to treat the O44K74 cells to achieve a higher yield of biotransformation. 
However, chemical treatment of cells can often incur unintended damage to cells (even 
lysis), and generate serious downstream problem, especially when detergent is used. Our 
previous studies, ,  demonstrated that lpp lipoprotein mutation was extremely effective in 
accelerating whole cell biocatalysis rates towards various substrates. Since the reaction 
rates were decided by measuring the product concentrations outside the cells, the increase 
in the reaction rates should also be attributed to the fast product export due to the 
mutation. In this study, an lpp knockout strain E. coli O44K74Y was generated using a 
previously reported gene inactivation method to evaluate the mutational effect on the L-
carnitine export and product yield. 
5.3.4.1 Time course of L-carnitine production 
 Cells of lipoprotein mutant E. coli O44K74Y and O44K74 were grown under 
the anaerobic conditions as described in 5.2.5.1. The biotransformation was performed 
aerobically using resting cells (~20 g wet cell/liter) suspended in 60 mM potassium 
phosphate supplied with 50 mM crotonobetaine. The time course of biotransformation 
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process was monitored by measuring the L-carnitine concentration as shown in Figure 5–
5. The biotransformation started off quickly in the first two hours, with initial production 
rates of 3.0 g l-1 h-1 and 2.7 g l-1 h-1 for mutant and parent strain, respectively. The product 
concentration of the both strains increased slowly in the following four hours and reached 
maximum level after overnight incubation. The L-carnitine yield for lipoprotein mutant 
O44K74Y reached 56%, about 30% increase over the yield of its parent strain, 43%. 
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Figure 5–5. Time course of L-carnitine production by whole-cell E. coli O44K74Y () 
and O44K74 (U), with 50 mM initial crotonobetaine and ~20 g wet 
cell/liter biomass. Error bars represent standard deviations from the mean. 
All data are measured in three separate experiments. 
  
 From Figure 5–5, it is apparent that initial rates of both strains were very fast, 
with around 31% and 36% yield in the first hour for parent and mutant strains, 
respectively. Compared with the parent strain, the initial production rate of the mutant 
strain was only about 10% higher, which indicated that the membrane mutation did not 
have significant effect on permeability of hydrophilic substrate crotonobetaine and 
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product L-carnitine at the beginning of the reaction. Our earlier studies showed dramatic 
increases of 4– and 14–fold in the initial rates were achieved by the same lipoprotein 
mutation with hydrophilic substrates, nitrocefin and UDP-glucose, respectively, . 
However, this different observation with L-carnitine production is expected since both L-
carnitine and crotonobetaine are relatively small molecules (MW~200) compared with 
nitrocefin and UDP-glucose (MW~600). The passage of these two small hydrophilic 
molecules through the outer membrane should be comparatively faster because they are 
far below the maximum size that allowable through the porin channels (600–700 
Daltons). 
 The difference in the product concentrations between mutant and parent 
increased as the biotransformation continued. The final L-carnitine concentrations of 
mutant and parent strain were of 28.0 mM and 21.6 mM, respectively. Based on 50 mM 
crotonobetaine input, the product yield of the mutant strain was about 56%, which is 30% 
higher than that of the wild-type strain, 43%. The result suggests that the effect of 
lipoprotein mutation is more pronounced in the later phase of the reaction. Since the 
biotransformation catalyzed by L-carnitine dehydratase is a reversible reaction, we expect 
that the reaction would reach its equilibrium at a certain point depending on the 
intracellular concentrations of L-carnitine and crotonobetaine. Also, the L-carnitine yield 
is limited by the product degradation by side reaction. Therefore, the higher product yield 
by the mutant cells can be attributed to the faster product export that drives the reaction 
forward and reduces the product degradation. In order to demonstrate the advantage of 
mutant cells, further experiments were performed with multiple substrate replenishments.  
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5.3.4.2 Biotransformation with substrate feedings  
 To further evaluate the potential of the lipoprotein mutant for L-carnitine 
production, reactions with substrate feedings were performed as shown in Figure 5–6. 
The resting-cell reactions were able to continue for 48 hours with two 100 mM 
crotonobetaine replenishment at 4th and 24th hour. No further increase in the product 
concentrations were observed after a third addition of crotonobetaine at 48th hour due to 
the depletion of cell material and energy for the biotransformation, 64.  
 Figure 5–6 showed that the L-carnitine production rates were about 1.8 g l-1 h-1 
and 1.6 g l-1 h-1 for the mutant and parent strains in the first two hours. The production 
rates reduced to 1.0 g l-1 h-1 and 1.2 g l-1 h-1 after the first substrate addition, 37% and 
33% reduction for mutant and parent strains. After the first substrate addition, the L-
carnitine concentrations reached 63 mM and 50 mM at 24th hour for mutant and parent, 
respectively. Their respective product yields were 42% and 33% based on 150 mM 
crotonobetain input (after one substrate replenishment). The production rates after the 
second substrate addition further decreased to 0.1 g l-1 h-1, less than 10% of the level of 
the first round. After 48 hours of reaction, the final L-carnitine concentrations of the 
mutant and parent strain were 84 mM and 59 mM, corresponding to yields of 34% and 
24% (based on a total input of 250 mM after two substrate replenishments), respectively. 
From Figure 5–6, it’s evident that the difference in the product yield between two strains 
increased as the reaction continued, with 42% higher yield achieved by the mutant. This 
also indicates that the lipoprotein membrane mutation is capable of enhancing the L-
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carnitine yield without affecting the stability and durability of the whole cells as 
biocatalysts. 
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Figure 5–6. Time course of L-carnitine production catalyzed by whole-cell E. coli 
O44K74Y () and O44K74 (U) with 50 mM initial crotonobetaine and 
two100 mM crotonobetaine replenishments at 4th and 24th hour. Arrows 
represent two substrate feedings. Error bars represent standard deviations 
from the mean. All data are measured in three separate experiments. 
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5.4 Discussion 
A Braun’s lipoprotein transposon mutation was found to be effective in 
accelerating the reaction rates of whole-cell biocatalysis utilizing substrates with different 
size and hydrophobicity, , . The enhancement in the reaction rates ranges from 1.5–fold to 
as high as striking 14–fold. In order to find out the genetic changes corresponding to this 
phenotype, the lpp region of this lipoprotein mutation E609L were sequenced and 
compared with control strain. It turned out the lpp is completely inactivated by a 59-bp 
insertion containing two double-stop codon at the beginning of lpp gene. Therefore, we 
believe that the same phenotype could be obtained by deleting the lpp gene from the 
chromosome DNA of any E. coli strain of interest. A generally applicable methodology 
was established for accelerating whole-cell biocatalysis employing a high efficient gene 
inactivation procedure. The characterization of lpp deletion strain showed that the mutant 
grew as fast as the parent strain in both rich and minimal medium and exhibited the same 
glucose consumption rate as the parent strain under both aerobic and anaerobic conditions. 
The mechanisms related to these observations have yet to be discovered. Some minor 
changes in the fatty acid compositions were detected (<5%), including the decrease of 
short-chain (C14:0~C16:0) and cyclopropane fatty acids levels and the increase of long-
chain fatty acids (C17:0~C18:0) level. It suggestes that the lipoprotein mutant cells could 
manage to modulate the proportions of fatty acids as a response to the lipoprotein defect. 
The results also imply that compensation mechanisms are likely to exist in different 
aspects of growth and metabolism to help maintenance and function for the mutant cells. 
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This study demonstrates that a useful lpp lipoprotein mutation can be applied to 
solve the general permeability problems in whole-cell biocatalysis process. The lpp 
knockout strains can be generated with a straightforward and high efficient gene 
inactivation method. In this study, the lpp deletion was successfully introduced into E. 
coli strains with different genetic background for accelerating whole-cell biocatalysis. An 
example was illustrated using L-carnitine production strain E. coli O44K74 with 30~42% 
increase in product yield. 
 We applied the useful lipoprotein mutation to L-carnitine production strain E. coli 
O44K74 to achieve higher product yield. The fast initial production rates of both strains 
indicated that the effect of membrane mutation on the permeability of product and 
substrate (L-carnitine and crotonobetaine) was not significant at the beginning of the 
reaction due to their low MW. Only 10% difference in the initial production rates was 
observed in the first two hours. The effect of lipoprotein mutation was more pronounced 
in the later phase of the reaction, with a product yield of 56% achieved by the mutant 
strain, 30% increase over the yield of the parent strain, 43% (based on an input of 50 mM 
crotonobetaine). The results suggest that the lipoprotein mutant cells are able to achieve 
higher product yield by faster product export, which is crucial for forwarding the 
reversible reaction and releasing the product from degradation in the L-carnitine 
production. Further substrate feeding experiments confirmed the beneficial effect of 
mutation on the L-carnitine production. The reactions were continued for 48 hours, and 
the final L-carnitine yield after two substrate feedings were 42% higher than that of the 
parent strain. This also indicates that the lipoprotein membrane mutation is capable of 
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enhancing the L-carnitine yield while maintaining the stability and durability of the 
whole cells as biocatalysts. These results demonstrate that a useful phenotype can now be 
transferred to any E. coli strain of interest with a straightforward genetic manipulation to 
effectively enhance the rate of a whole-cell biocatalysis reaction. This method might be 
generally applicable to biocatalysis processes as the permeability change effected by the 
mutation is of global nature.  
 CHAPTER 6 Summary 
 
 
The past two decades has seen tremendous progress in the research of using 
biocatalysts for the synthesis of high-value fine chemicals. Compared with isolated 
enzymes, whole-cell biocatalysts can be much more readily and inexpensively prepared 
on an industrial scale. Whole-cell biocatalysts are more stable than their isolated 
counterparts and allow reaction involving multi-enzymes even multi-pathways,. 
However, one major problem in whole-cell catalysis is the mass transfer limitation 
imposed by the cell envelopes. As a result, the reaction catalyzed by the whole-cells is 
often orders of magnitude slower than that of the isolated enzymes. Until recently, the 
only effective way to address this was to permeabilize cells by chemical (such as 
detergent, solvent, and chelators) or physical (such as extreme temperature fluctuations) 
treatment, . These methods are far from being desirable, especially for large scale 
applications, since they create additional steps in manufacturing processes, complicate 
downstream processing, and incur unintended damage to cells.  
In this study, we successfully reduced the membrane permeability barrier of E. 
coli strains by genetically altering the membrane structure. A lipopolysaccarides E. coli 
mutant (SM101) and a Braun’s lipoprotein mutant (E609L) were used in this study. As 
our first test, two large model substrates (MW~600) that differ substantially in 
hydrophobicity, nitrocefin, and a tetrapeptide N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide 
were employed to interrogate the outer membrane of the cells. The reduction of the outer 
membrane permeability by genetic methods led to significant increases (up to 380%) in 
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reaction rates of whole-cell catalyzed reactions. The magnitude of the increase in 
biocatalysis rates was also found to be dependent on the substrates and on the nature of 
the mutations introduced in the outer membrane structure. Notably, the 
lipopolysaccarides mutations can render the outer membrane completely permeable to the 
tetrapeptide, a barrier-less condition that maximizes the reaction rate. Subsequently, the 
toluene dioxyengase (TDO)-catalyzed reaction was investigated to investigate the effect 
of lipoprotein mutation on small, hydrophobic substrates. Dramatic enhancement of the 
reaction rate, an increase of up to six fold, was observed over a wide range of substrate 
concentrations. We also studied the effects of outer membrane mutations on a hydrophilic 
large molecule, UDP-glucose (MW~600) in whole-cell systems. Owing to the severe 
limitation in substrate permeability, the wild type cells only exhibited as low as 4% of 
available enzyme activities. Reducing the barriers of the outer membrane permeability 
led to a striking acceleration (up to 14–fold) of reaction rate in cells expressing UDP-
glucose dehydrogenase. Mutations in the lipopolysaccharide synthesis pathway or 
Braun’s lipoprotein are both effective. An application of outer membrane mutants was 
illustrated with the synthesis of a disaccharide (N-acetyllactosamine) from UDP-glucose. 
Both reaction rate and product yield were enhanced significantly (more than two fold) in 
the lipoprotein mutant, demonstrating the importance of the outer membrane permeability 
barrier and the advantages of using outer membrane mutants in synthesis.  
The impact of membrane mutations was compared with a known potent 
permeabilizer PMBN (polymixin B nonapeptide). It showed that membrane 
modifications to enhance the permeability of hydrophilic molecules should target the 
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Lipid A region. However, molecular engineering strategies other than reduction of Lipid 
A synthesis should be considered. Our study also illustrated that the mutations were much 
more effective than the commonly used EDTA treatment and freeze-thaw (FT) 
permeabilizing procedure. Therefore, our results demonstrated the clear advantages of 
using genetic modification in cellular membrane engineering for improved whole-cell 
catalysts. 
Our studies, ,  with a Braun’s lipoprotein mutant E609L demonstrated that Braun's 
lipoprotein transposon mutation in outer membrane could be an effective method to 
increase permeability of a variety of substrates. The mutant exhibited a normal growth 
rate and expressed the recombinant multi-component enzyme as well as the isogenic 
parent strain. The results showed that reactions with all six substrates were dramatically 
accelerated by this lipoprotein mutation (up to 14–fold increase in reaction rate). In order 
to establish this as a generally applicable methodology for accelerating whole-cell 
biocatalysis, we investigated an alternative genetic modification to obtain the same 
phenotype. The lpp gene deletion was successfully introduced into E. coli strains from 
different genetic background and characterized. It showed that the deletion had the same 
effect on substrate permeability as the original transposon mutation. Also, the lpp 
deletion was found to have no significant effect on cell growth, carbon metabolism, and 
lipid compositions. As an example, the lpp deletion strain E. coli O44K74Y was 
successfully applied in L-carnitine production with 42% increase in product yield. These 
results demonstrate that a useful phenotype can now be transferred to any E. coli strain 
with a straightforward genetic manipulation to effectively enhance the rate of a whole-
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cell biocatalysis reaction. This method might be generally applicable to biocatalysis 
processes as the permeability change effected by the mutation is of global nature. 
This research and the results outlined in this dissertation point to a valid strategy 
in addressing permeability issues in whole-cell biocatalysis. It also highlights a need for 
an assessment of substrate permeability in biocatalysis research and development. Future 
study should be focused on, 
1. Application of the lipoprotein mutation in non-E. coli Gram-negative bacteria strains. 
2. Investigation of the relationship between the lipoprotein mutation to other important 
substrate properties, such as spatial structure, group size and charge. 
3. Investigation of the potential effect of outer membrane mutations at other loci, such 
as integral protein of outer membrane, peptidoglycan. 
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APPENDIX 1.1 
 
 
A short Glossary: Terminology Used in the Dissertation 
 
Mutation: A change of the DNA sequence within a gene or chromosome of an 
organism resulting in the creation of a new character or trait not found in the parent cell. 
Natural mutations can occur spontaneously or in response to environmental factors such as 
radiation and mutagenic chemicals. In this study, mutations were introduced into E. coli 
strains using molecular engineering techniques.  
Mutant: A cell or organism that has been genetically changed as a result of 
mutation. The original cell is called the parent or wild-type cell. 
Substrate: Substrate refers to the reactant of an enzymatic reaction. 
Membrane permeability: The capability of cell membrane to allow the passage 
of substrates tested. Permeability depends on both the nature of the membrane structure 
and the physical properties of the substrate. In this study, the permeability is evaluated by 
the reaction rate of a whole-cell catalyzed reaction.  
Reaction rate: In this study, the term reaction rates refers to apparent or observed 
rates of substrate utilization by host cells. Reaction rate was inferred from product 
measurement. 
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